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Nonribosomal peptide synthetases (NRPSs) are enzymatic systems found in bacteria and 
fungi responsible for the production of complex secondary metabolites. NRPSs are able 
to generate a remarkably diverse array of natural products from simple starting materials. 
This is due to their modular nature and assembly-line organization in which the growing 
product is passed from module to module with an individual monomer incorporated at 
each step. 
The modular nature of NRPSs makes them an attractive tool for synthetic biologists to 
generate novel natural products with desirable pharmaceutical or industrial properties. In 
principle, existing modules could be rearranged in a combinatorial fashion to produce an 
enormous number of new products. However, in practice this has not been successful, 
likely due to a lack of understanding of the mechanisms underlying NRPS synthesis. 
Each module is made up of at least three domains whose combined function leads to the 
selection, activation, and incorporation of a small molecule into the growing product. 
Domains called carrier proteins are first modified from an inactive apo form to an active 
holo form in which a 4’-phosphopantetheine (PP) moiety is attached to a conserved 
serine. Adenylation domains then select and activate a small molecule using ATP via 
formation of an acyl-adenylate and then load the small molecule onto a holo-carrier 
protein via formation of a thioester with the terminal thiol of the PP arm. Condensation 
domains then catalyze amide bond formation between substrates loaded on adjacent 
carrier proteins. During synthesis, individual domains must move relative to one another. 
Domains are also subject to both small and large-scale conformation changes. NRPS 
synthesis is therefore a complex process involving the interplay of catalysis, covalent 
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modification, and conformational rearrangements. Understanding how these processes 
are orchestrated to achieve efficient synthesis will be necessary for rationally redesigning 
these systems. 
Here, I present my work aimed at dissecting the role of covalent modifications to carrier 
proteins in altering their structure and how this, in turn, modulates interactions with 
adenylation domains. In order to study the structure of a carrier protein in all of its forms, 
we first developed a novel method to characterize the loaded form by nuclear magnetic 
resonance (NMR) spectroscopy. We then solved the solution structures of a CP in all of 
its forms and characterized the NMR dynamics of the holo and substrate-loaded forms. 
Finally, we characterized the interaction between a carrier protein and an adenylation 
domain by fluorescence anisotropy, isothermal titration calorimetry, and NMR titration. 
Our results show that covalent modifications alter the structure and dynamics of the 
carrier protein and prosthetic moieties in a way that provides directionality to the 
interaction with the adenylation domain that parallels the chemical steps of elongation 
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Chapter 1-Introduction to Nonribosomal Peptide Synthetases 
Nonribosomal peptide synthetases (NRPSs) are enzymatic systems found in bacteria and 
fungi that are responsible for the production of diverse secondary metabolites. These 
complex natural products serve a wide variety of functions, including scavenging trace 
metals from the environment (including host organisms) and killing other bacteria or fungi. 
These natural functions have made NRPs valuable pharmaceutical agents and many 
antibiotics, anti-cancer agents, and immunosupressants are NRPs or derivatives thereof1. 
The products made by NRPSs cover an enormous amount of chemical space. They vary 
greatly in both size and composition and include many chemical moieties not found in 
ribosomally produced peptides, including heterocycles, D-amino acids and aryl acids.  
Despite their dissimilar structures, NRPs are all produced by a conserved mechanism in 
which the final products are built in an assembly-line fashion out of simple starting 
materials. Central to this synthetic strategy is the modular nature of NRPSs (Figure 1-1A). 
Each module, composed of multiple domains, is responsible for selecting, activating, and 
incorporating a single small molecule into the growing peptide before passing it to the 
downstream module1. This modular nature has made NRPS an attractive target for 
synthetic biologists, as swapping modules with differing substrate specificities could, in 
principle, generate new peptides with novel pharmaceutical or industrial properties (Figure 
1-1B). However, this has not yet emerged as an efficient means of generating novel natural 
products, most likely due to the complex interplay between catalysis, covalent 
modification, and protein-protein interactions that underlies NRPS synthesis and is still 
poorly understood. 
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A canonical module is composed of three different domains: an adenylation (A) domain, a 
carrier protein (CP), and a condensation (C) domain (Figure 1-2A). The CP first has to be 
converted from an inactive apo form to an active holo form via covalent attachment of a 
4’-phosphopantetheine (PP) arm to a conserved serine by a phosphopantetheinyl 
transferase (PPTase) (Figure 1-2B). A domains then select a small molecule to be 
incorporated and, using ATP, activate the substrate by forming a high-energy acyl-
adenylate. The activated substrate is then loaded onto the holo-CP via formation of a 
thioester with the PP arm (Figure 1-2C). The CP delivers the tethered substrate to an 
upstream C domain, which catalyzes peptide bond formation between the tethered 
monomer and an intermediate product loaded on an upstream CP. The CP then delivers the 
elongated product to a downstream C domain, where it is unloaded onto a downstream CP. 
This process continues until the final product is formed (Figure 1-2D) and a thioesterase 
(TE) domain catalyzes hydrolysis to form a linear product or macrocyclization1. 
NRPS synthesis is a highly complex process that involves CPs cycling between two or 
more biochemical states, catalytic domains carrying out multiple chemical reactions and 
undergoing large-scale conformational changes, and a set of many transient protein-protein 
interactions (Figure 1-3). All of these processes take place while a labile intermediate is 
covalently attached to the synthetase via the PP of a carrier protein. Understanding how 
the interplay between covalent modification, catalysis, and protein-protein interactions is 
orchestrated to optimize the transfer of labile peptide intermediates between active sites is 
key to delineating the mechanism of NRPS synthesis and providing a rationale for 
reengineering these systems to produce novel products.  
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Carrier proteins play a central role in NRPS synthesis, as intermediate products are 
covalently tethered to CPs via the PP arm when they are shuttled between multiple active 
sites. As such, CPs exist in many different biochemical forms (apo, holo, monomer-loaded, 
intermediate-loaded) and must interact with many different catalytic domains (PPTase, A 
domain, upstream and downstream C domains). Discerning the mechanism of NRPS 
synthesis thus requires knowledge of the structure of CPs in all the different forms and an 
understanding of the energetics governing the entire set of protein-protein interactions in 
which they participate. 
The first structure of an apo-CP from a NRPS system2 (tyrocidine synthetase) showed that 
NRPS CPs fold into the four-helix bundle that typifies the structure of CPs from NRPS, 
polyketide synthase (PKS), and fatty acid synthase (FAS) systems3. The four-helix bundle 
is comprised of 3 longer helices (α1, α2, and α4) that run parallel/antiparallel to one 
another in an up, down, down arrangement and a shorter helix (α3) that lies almost 
perpendicular to the other three. The loops connecting the helices are of variable length, 
with loop 1 being very long and dynamic, loop 2 being shorter but still flexible, and loop 
3 being short and relatively rigid. Single-turn helices are also frequently found within loop 
1. The conserved serine onto which the PP arm is covalently attached is found at the 
junction between loop 1 and helix 2. 
Attachment of the PP arm to generate a holo-CP has been reported to have a wide range of 
effects on the structure of CPs. Some studies have reported that phosphopantetheinylation 
has no effect on the structure and found no evidence of an interaction between the CP and 
PP arm2,4 while others have reported that holo-CPs exist in a conformational equilibrium 
between two distinct structures, both of which show a strong interaction with the PP arm 
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but differ in the interaction surface5. We found6 (Chapter 3) that the PP arm has a well-
defined interaction with a CP but is still highly dynamic and likely interconverts between 
a rigid, bound state and a flexible, unbound state. A recent solution structure of a holo-CP 
from a different NRPS system also found a well-defined interaction between the CP and 
PP arm7. In Chapter 4, I attempt to use the structures of apo-CPs to reconcile the disparate 
reports and suggest that the model we proposed, in which the PP arm rapidly interconverts 
between an unbound and one (or more) unbound forms, is common to all NRPS CPs. 
Structures of a loaded-CP from a NRPS system were only solved recently6,7. The labile 
nature of the thioester bond between the loaded substrate and the PP arm limits the lifetime 
of a loaded-CP to the point that it can not be characterized by traditional NMR methods. 
To overcome this limitation, two complementary strategies were developed and utilized. 
Our lab developed a method to generate the loaded form directly in situ in the NMR tube8 
(Chapter 2) while the Burkart lab utilized a one-pot enzymatic reaction to activate and 
attach a nonhydrolyzable analog of substrate-loaded pantetheine to a CP7. Both studies 
found that NRPS CPs interact directly with the tethered substrate, wherein the substrate 
lies along a shallow groove formed by residues from loop 1, helix 2, and helix 3. We also 
found that substrate loading rigidifies the PP arm, although it still maintains some 
flexibility and, like the unloaded PP arm of a holo-CP, interconverts between a bound and 
unbound form. Finally, we found that the different placement of the PP arm in the holo and 
loaded structures obscures or exposes different binding surfaces and may, in this way, 
modulate interactions with A domains.  
Structural and dynamic studies have now provided a detailed view of NRPS CPs in many 
of their biochemical states. We now understand how these covalent modifications alter the 
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structure of the CP itself and how they interact with the core of the CP. However, these 
structural and dynamic changes only gain significance when we consider how they 
influence protein-protein interactions and must therefore consider how these modifications 
modulate binding between CPs and catalytic domains. 
Adenylation domains are large (~55-60 kDa) catalytic domains responsible for first 
selecting and activating small molecule substrates and then loading them onto holo-CPs in 
two distinct reactions9. A domains are comprised of two subdomains, a large N-terminal 
domain and a smaller C-terminal domain, and the active site for the chemical reactions lies 
at the interface of the two subdomains (Figure 1-4)9. Notably, the C-terminal domain 
contributes a different set of residues to the active site for each of the two reactions9. 
Crystallographic studies have shown that A domains adopt the so-called adenylation 
conformation for the first reaction, activation of the substrate with ATP to form an acyl-
adenylate9. The C-terminal domain then rotates almost 140 degrees to adopt the thiolation 
conformation, in which it binds to a holo-CP and catalyzes substrate loading9. A third 
arrangement, the open conformation, has also been observed and is proposed to be present 
before substrates (amino acid and ATP) are bound9. A domains can thus exist in at least 
three conformations that differ in the relative orientation of the N- and C-terminal domains 
as they progress through their catalytic cycle (Figure 1-4).  
Interaction between A domains and CPs has thus far only been observed with an A domain 
in the thiolation conformation and a holo-CP. The interaction between these two domains 
is transient and does not crystallize on its own. Multiple groups have used suicide inhibitors 
to trap holo-CPs in complex with an A domain and have solved crystal structures of a 
complex between an isolated CP and isolated A domain10, an A domain:CP fusion protein11, 
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and the interaction within the context of full modules12,13. These structures have 
consistently identified interactions between the N-terminal domain of A domains and 
helices 2 and 3 of a CP. The first two structures also claimed to identify an interaction 
between the C-terminal domain and loop 1 of the CP, but this has not been described in all 
reports of A domain:CP complexes12,13. The nature of the interaction between an A domain 
and an apo- or loaded-CP is not yet known. 
Years of work studying NRPSs has yielded a thorough biochemical description of 
nonribosomal peptide synthesis and begun to formulate a structural basis for understanding 
the mechanism of NRP synthesis. Structures have provided snapshots of individual 
domains, di-domains, and entire modules in various states2,6,7,10,12–14. However, what is 
necessary for a complete mechanistic understanding of NRP synthesis is a measurement of 
the forces driving transitions between these various states. Only a limited number of studies 
have addressed how substrate binding or competition amongst binding partners modulates 
the structure and interactions of NRPS domains14,15. 
Here, I present my work investigating how covalent modifications to a an aryl carrier 
protein (ArCP) from the yersiniabactin synthetase system influence the structure and 
dynamics of the CP itself and how this, in turn, modulates interactions with partner 
catalytic domains. In order to study all forms of ArCP, I first developed a novel method for 
studying loaded forms of NRPS CPs by NMR8 (Chapter 2). I then solved the solution 
structure of apo-ArCP (Chapter 4) and solution structure and dynamics of holo-, and 
loaded-ArCP6 (Chapter 3), and, finally, characterized the interactions between the three 
forms of ArCP and the A domain YbtE by fluorescence anisotropy, isothermal titration 
calorimetry, and NMR titrations (Chapter 5). What emerges is a picture in which covalent 
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modifications to a CP alter the structure and dynamics of both the CP and the covalent 
modifications themselves. This, in turn, modulates the interactions with YbtE in a manner 
that provides a directionality to the set of protein-protein interactions that parallels the 
chemical steps of peptide elongation. The work presented here begins to address the 
mechanisms underlying protein-protein interactions in NRPS synthesis and will provide a 




Figure 1-1. A) NRPSs are organized into modules. Each module is specific for a single 
small molecule, shown as a green square, purple hexagon, or orange octagon. The 
growing product is passed from module to module and monomers are incorporated in the 
order in which the modules are arranged. B) Since the order of the modules dictates the 
order in which small molecules are incorporated, swapping the order of modules could 




Figure 1-2. A) Each module is made up of a number of domains, including adenylation 
(A), carrier protein (CP), and condensation (C) domains. The green module is an initiation 
module and therefore has no C domain. B) CPs must be activated from an apo to a holo 
form by a phosphopantetheinyl transferase (PPTase). These enzymes catalyze the 
attachment of 4’-phosphopantetheine (PP) to a conserved serine found on all CPs. C) 
Adenylation domains select a small molecule substrate, activate it with ATP by forming 
an acyl-adenylate, and load it onto the PP arm via formation of a thioester. D) Condensation 
domains catalyze formation of amide bonds between products loaded on adjacent carrier 
proteins until the final product is attached to the terminal CP. This regenerates the holo 
form of the CPs so another round of synthesis can occur. The final product will be 





Figure 1-3. Central role of carrier proteins in NRPS synthesis. Carrier proteins are 
involved in every step of NRPS synthesis, from priming to elongation. They are first 
covalently activated from an apo to a holo form. During the course of elongation, they 
become loaded with a substrate and then donate the substrate to a downstream carrier 
protein, regenerating the holo form. These steps require interactions with a PPTase, an 
adenylation domain, and a condensation domain, at a minimum. Each form of a carrier 
protein is a substrate for a different enzyme, indicated with the bold arrow. However, every 
form may interact with every enzyme and it is unknown how, or if, enzymes discriminate 




Figure 1-4. Domain alternation in adenylation domains. Adenylation (A) domains have 
been found to exist in at least three different conformations, each of which is proposed to 
play a different role in catalysis. The open conformation (luciferase, PDB 1LCI) is 
expected to be the major conformation present before substrates have been bound. The 
adenylation conformation (DhbE, PDB 1MDF) catalyzes formation of the acyl-adenylate 
and the thioester conformation (EntE, PDB 3RG2) binds to a holo-carrier protein and 
catalyzes substrate loading. Structures were aligned based on their N-terminal domains and 
a homologous helix is highlighted in red in each structure to show the changing position of 
the C-terminal domains.   
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Chapter 2-A nuclear magnetic resonance method for probing molecular influences of 
substrate loading in nonribosomal peptide synthetase carrier proteins 
 
This chapter was published with minor modifications in Biochemistry, January 2015, by 
Andrew Goodrich and Dominique Frueh. 
 
ABSTRACT: Carrier proteins (CPs) play a central role in nonribosomal peptide 
synthetases (NRPSs) as they shuttle covalently attached substrates between active sites. 
Understanding how the covalent attachment of a substrate (loading) influences the 
molecular properties of CPs is key to determining the mechanism of NRPS synthesis. 
However, structural studies have been impaired by substrate hydrolysis. Here, we used 
nuclear magnetic resonance spectroscopy to monitor substrate loading of a CP and to 
overcome hydrolysis. Our results reveal the spectroscopic signature of substrate loading 
and provide evidence of molecular communication between an NRPS carrier protein and 
its covalently attached substrate. 
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Nonribosomal peptide synthetases (NRPSs) are bacterial and fungal enzymatic systems 
that produce complex secondary metabolites from simple starting materials such as amino 
or aryl acids, many of which have found use as antibiotics and anti-cancer agents16. NRPSs 
possess a remarkable assembly line architecture, in which substrates are covalently 
attached to contiguous modules and condensed to form the final product. Each module is 
comprised of a core set of conserved domains and a long standing goal of the field is 
swapping domains or modules with differing substrate specificities so as to generate novel 
pharmaceuticals17. Unfortunately the molecular mechanisms of NRPS synthesis, and 
particularly domain communication, remain largely unknown, impeding progress in 
reprogramming NRPS assembly lines. Amongst NRPS domains, carrier proteins (CPs) 
play a central role as they tether the substrates to the assembly line and, hence, they visit 
many catalytic domains during NRPS synthesis. CPs are first converted from an inactive 
apo to an active holo form via covalent attachment of a 4’-phosphopantetheine arm (PP) 
onto a conserved serine. Next, adenylation (A) domains catalyze both substrate adenylation 
and thioester bond formation between the activated substrate and the PP of holo carrier 
proteins to generate a substrate loaded CP. Finally, condensation domains catalyze the 
peptide bond formation between two substrates loaded on neighboring CPs to extend the 
peptide. NMR and crystallographic studies indicate that NRPS modules are not rigid, but 
their domains are subject to inter- and intra-domain dynamics5,9,14,18,19. Moreover, 
attachment of the PP altered the structure and dynamics of an isolated CP5. Studies of 
structurally related fatty acid synthases (FAS) and polyketide synthases (PKS) have 
implicated substrate loading in influencing large scale domain rearrangements20,21. 
However, the lability of NRPS substrate thioester bonds has precluded similar studies of 
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loaded NRPS carrier proteins. Understanding how CPs efficiently orchestrate sequential, 
transient interactions with partner domains and elucidating the role of tethered substrates 
in modulating these interactions is of vital importance to understanding NRPS assembly 
line synthesis and, ultimately, rationally redesigning these systems. Here, we exploited the 
non-invasive nature of nuclear magnetic resonance (NMR) to overcome hydrolysis and 
study a loaded aryl carrier protein (ArCP) from yersiniabactin synthetase. Our results 
reveal that NRPS ArCPs interact either directly or indirectly with the substrates attached 
at the end of the 20 Å long PP. 
In the yersiniabactin synthetase system, the free-standing A domain YbtE initiates 
synthesis by loading salicylate (Sal) onto the holo aryl carrier protein of the multidomain 
protein HMWP222. The excised ArCP was overexpressed in E. coli BL21 (DE3) ΔEntD 
cells (a gift of Drs. Chalut and Guilhot) and purified to yield pure, homogeneous apo ArCP. 
Apo ArCP was phosphopantetheinylated in vitro and purified to obtain holo ArCP. To 
study the loaded form of ArCP, two major obstacles had to be addressed: hydrolysis and 
transthiolation from thiol containing reducing agents23, which were necessary to prevent 
disulfide bond formation in holo ArCP. Transthiolation was avoided by using tris(2-
carboxyethyl)phosphine as a reducing agent. Although hydrolysis of thioesters is slower 
than transthiolation, it was rapid enough to preclude quantitative analysis of loaded ArCP.    
Indeed, when ArCP was loaded with Sal (confirmed by MALDI mass spectrometry 
(MALDI MS)) and freshly purified, NMR spectra featured signals of both holo ArCP and 
a previously unobserved form. Unfortunately, the new signals decreased over time, raising 
the possibility that they were an artifact of sample preparation and not reporters of substrate 
loading. Purified, loaded ArCP was therefore unsuitable for NMR studies. 
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To allow for prolonged detection of loaded ArCP, we exploited the isotope editing ability 
of NMR, and we generated the loaded form in situ to bypass the need for purifying loaded 
ArCP. Sal and ATP (2 mM each) were added in large excess to 15N-labeled holo ArCP (300 
µM). No interaction between holo ArCP and the reagents was detected in HN-HSQC 
spectra (Figure 2-3). We then added catalytic quantities of YbtE (100 nM) and collected a 
series of HN-HSQCs. At such concentrations, the binding of YbtE to ArCP does not induce 
shifts in NMR signals. During the reaction, signals of loaded ArCP increase while signals 
of holo ArCP decay (as shown for the phosphopantetheinylation site, Ser52, in Figure 2-1 
A1, B1-4). MALDI MS confirmed the conversion into ArCP loaded with Sal. To 
demonstrate that all signals observed by NMR report on substrate loading and not some 
undesired side effects, we induced substrate hydrolysis by enzymatic catalysis. We added 
the promiscuous thioesterase SrfTEII24 to purified loaded ArCP, and the NMR signals of 
loaded ArCP disappeared as those of holo ArCP reappeared (Figure 2-1 A2, B5-7). The 
HN-HSQC collected following the completion of SrfTEII-catalyzed hydrolysis (confirmed 
by MALDI MS) overlays perfectly with that of holo ArCP, demonstrating that the new 
peaks observed upon incubation of holo ArCP with ATP, Sal, and YbtE are indeed the 
spectroscopic signature of substrate loading (Figure 2-7). Comparison between the kinetics 
of uncatalyzed hydrolysis (Figure 2-6) and substrate loading suggested that hydrolysis may 
be compensated by continuous reloading of Sal on ArCP. Indeed, spectra of loaded ArCP 
recorded after 5 days displayed no significant regeneration of holo ArCP in presence of 
YbtE, Sal, and ATP, whereas in the absence of YbtE, Sal, and ATP, ~57% of purified 
loaded ArCP hydrolyses over that time (Figures 2-8 and 2-6). Thus, adding catalytic 
amounts of the cognate A domain overcomes hydrolysis of loaded monomers for a duration 
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amenable for NMR studies. This method complements other strategies used to circumvent 
hydrolysis in loaded carrier proteins (SI, S6). 
The changes we observe in NMR spectra of loaded ArCP may reflect many molecular 
events. NMR signals in HN-HSQC report on the local chemical environment of the amide 
group of each residue. Differences between spectra of holo and loaded ArCP, so-called 
chemical shift perturbations (CSPs), can indicate a variety of events, such as direct contact 
with the salicylate moiety, repositioning of the PP, structural alterations, and modulation 
of dynamics. Figure 2-2A shows an overlay of holo and loaded ArCP spectra. Simple 
inspection reveals that no massive structural rearrangement occurs upon loading, since 
most signals are the same in both spectra. However, a significant number of peaks shift 
markedly, indicating that loading Sal impacts the related amide groups. To gain insights 
into the origins of the CSPs of holo/loaded ArCP, we assigned the 1H and 15N resonances 
of apo 15N-13C-ArCP using conventional experiments25,26 and transposed the assignment of 
apo ArCP to holo 15N-ArCP and to loaded 15N-ArCP with NOESY-HN-HSQC spectra. 
Figure 2-2B, C, and D highlight four peaks that show varying degrees of CSP. Mapping 
the largest CSPs (Figure 2-9) onto the secondary structure of ArCP as determined with 
chemical shift indexing27,28, reveals distinct clusters of residues affected by loading (Figure 
2E). CSPs of residues around the phosphopantetheinylation site (Ser52, N-terminus of 
helix 2) likely reflect a change in conformation of the PP. CSPs of residues in helix 3 
together with residues in the middle of helix 2 may indicate a direct substrate interaction 
reminiscent of that observed in PKS and FAS acyl carrier proteins29,30. In both FAS and 
PKS, changing tethered substrates repositions helices 2 and 331,32, and it was suggested that 
these structural variations may modulate binding events21. Various NMR experiments can 
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test if salicylate alters the structure and/or dynamics of ArCP and modulates protein-protein 
interactions. Our newly designed conditions will permit such measurements while ArCP 
remains loaded. 
 In summary, we used NMR to directly monitor NRPS substrate loading, thereby 
providing the first atomic level description of this process. We found that NRPS 
substrates directly or indirectly interact with their cognate carrier proteins. Whether 
substrates bind to CPs or induce conformational fluctuations, substrate loading is 
expected to modulate the binding affinity of CPs toward partner catalytic domains. 
Decades of biochemical studies have demonstrated interplay between carrier proteins and 
their substrates during catalytic steps involving various domains33,34 and our method 




Cloning of ArCP 14-93 
The Y. pestis irp2 gene (Accession Number AAM85957) fragment coding for residues 14-
93 of the protein HMWP2 (courtest Dr. Christopher T. Walsh, Harvard Medical School) 
was PCR amplified using the primers ArCPStartD14KpnI (5’-
CTCAGGATTCGCTGGGTACCGACAACCGCCACGCGGC-3’) to introduce a KpnI 
cut site and ArCPEndE93 (5’-
TATCGAGTCATTCTCGAGCCGCCTACTCAGGCGACCGGC-3’) to introduce an 
XhoI cute site and stop codon. The PCR product and target vector pETRP1B-GB1-TEV 
were digested with KpnI and XhoI, gel purified, and extracted. The fragment coding for 
residues 14-93 was ligated into pETRP1B-GB1-TEV (courtesy Dr. Wolfgang Peti, Brown 
University) to yield pETRP1B-GB1-TEV-ArCP14-93. The resulting plasmid directs 
production of residues 14-93 of HMWP2 with an N-terminal GB1 tag followed by a 
hexahistidine tag and a TEV cleavage site. The DNA sequence of pETRP1B-GB1-TEV-
ArCP14-93 was confirmed by sequencing. Following TEV cleavage, a GT sequence 
remains at the N-terminus. 
Cloning of YbtE 
The gene coding for the full length YbtE (Accession Number CAA21394) was cloned in 
two steps. The YbtE gene was PCR amplified from pPROEX-1 (courtesy Dr. C.T. Walsh) 
using the primers YbtE-XhoI-Reverse (5’- 
TGTCTCGAGTCGGTTTGCGCTTATTGGGCAG-3’) to introduce a XhoI cut site and 
YbtE-NdeI-Forward (5’-CTGTATTTTGAGGGCGCCCATATGAATTCTTCC-3’) 
which overlapped with an existing NdeI cut site. The PCT produce and target vector 
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pETRP1B were digested with NdeI and XhoI and gel purified. The insert was ligated into 
the vector to give the plasmid pETRP1B-YbtE coding for full length YbtE with an N-
terminal hexahistidine tag followed by a TEV cleavage site. The YbtE gene was PCT 
amplified from pETRP1B-YbtE using YbtE-XhoI-Reverse and YbtE_KpnI_Forward 
(5’TTCATCATCATCATGGTACCGAAATCTTTATTTT-3’). The PCR product and 
target vector pETRP1B-GB1-TEV were digested with XhoI and KpnI and gel purified. The 
extracted products were ligated to yield pETRP1B-GB1-TEV-YbtE. This plasmid directs 
production of full length YbtE with an N-terminal GB1 tag followed by a hexahistidine 
sequence and a TEV cleavage site. The sequence of pETRP1B-GB1-TEV-YbtE was 
confirmed by sequencing. Following cleavage by TEV, a GH cloning artifact remains at 
the N-terminus. 
Protein Expression and Purification 
Unless otherwise noted, the pH listed for each buffer is the pH at 4 °C. 
pETRP1B-GB1-TEV-ArCP14-93 was transformed into competent E. coli BL21 (DE3) 
ΔEntD cells (courtesy Dr.s Chault and Guilhot, CNRS, Toulouse, France). A 2 ml culture 
of Luria broth (LB) with 50 µg/ml kanamycin was inoculated with a single transformed 
colony and grown at 37 °C and 225 rpm for 5-6 hours. 500 µl of this culture was added to 
200 ml M9 minimal media with 1 g/L 15NH4Cl as the sole nitrogen source for 
15 N-labeled 
samples and grown at 37 °C overnight. The 200 ml culture was added to 800 ml media and 
growth continued at 37 °C. At an optical density of 0.8 (600 nm), isopropyl β-D-1 
thiogalactopyranoside (IPTG) was added to 0.5 mM to induce protein expression. Cells 
were harvested 3-3.5 hours after induction at an optical density of 1.2-1.3. The cell pellet 
was resuspended in lysis buffer(50 mM Tris, pH 7.4, 325 mM MgCl2, 20 mM imidazole, 
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2% CHAPS (w/v), 2 mM phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml lysozyme) and 
lysed using a French pressure cell at 18,000 PSI. DNase I was added to the lysate to 10 
µg/ml and the lysate incubated on ice for 15 minutes. The lysate was clarified by 
centrifugation at 26,900 xg for 30 minutes. The supernatant was diluted 5-fold in 50 mM 
Tris, pH 7.4, 20 mM imidazole to reduce the concentration of CHAPS to 0.4% (w/v) and 
the concentration of MgCl2 to 65 mM and loaded onto a 5 ml HisTrap HP column (GE 
Healthcare). The column was washed with 30 ml His. Buffer A (50 mM Tris, pH 7.4, 1 M 
NaCl, 20 mM imidazole) and eluted with a linear gradient reaching 100% His. Buffer B 
(50 mM Tris, pH 7.4, 1 M NaCl, 500 mM imidazole) over 20 column volumes (CV) at a 
flow rate of 2 ml/min using an Aktapurifier (GE Healthcare). Fractions containing GB1-
TEV-ArCP14-93 were identified by SDS-PAGE, pooled, and dialyzed against 2 L Dialysis 
Buffer A (50 mM K2HPO4, pH 7.0, 2 mM EDTA) at 4 °C overnight. The dialyzed sample 
was loaded onto a 5 ml HiTrap Q HP column (GE Healthcare) using a peristaltic pump and 
washed with 20 ml Dialysis Buffer A. The flow-through containing GB1-ArCP-14-93 was 
collected and 1 OD280  TEV protease added per 20 OD280 sample to remove the GB1 and 
hexahistidine tags, and the sample dialyzed against 2 L Dialysis Buffer B (50 mM Tris, pH 
8.0, 0.3 M NaCl, 20 mM imidazole, 2 mM EDTA) at 4 °C overnight. Complete digestion 
of the sample to produce Gb1-His6 and ArCP was verified by SDS-PAGE. The dialyzed 
sample was loaded onto a 5 ml HisTrap HP column and washed with 20 ml Dialysis Buffer 
B. The flow-through containing ArCP was collected, concentrated using a 3K MWCP 
centrifugal filter (Millipore) and loaded onto a Superdex 75 16/60 pg column (GE 
Healthcare) that had been pre-equilibrated with 1.2 column volumes of NMR buffer (50 
mM ACES, pH 6.80 at 22 °C, 150 mM NaCl, 500 µM TCEP, 1 mM MgCl2). Peak fractions 
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were identified by SDS-PAGE and stored dilute at 4 °C. NMR samples of apo ArCP were 
concentrated to 0.3 mM. Concentration was determined by measuring absorbance at 280 
nm and using an extinction coefficient of 20970/M*cm. 
 
SrgTEII was grown at 37 °C to an optical density of 0.6 and then chilled for 1 hour in an 
ice bath. IPTG was then added to 1 mM and growth continued at 18 °C. Cells were 
harvested after 16 hours and the cell pellet resuspended in His. Buffer C (50 mM Tris, pH 
8, 0.5 M NaCl, 30 mM imidazole, 130 µg/ml lysozyme). Cells were lysed by sonication 
(15 cycles of 30 seconds on, 60 seconds off) and DNase I added to 3 µg/ml. The lysate was 
clarified by centrifugation at 26,900 xg for 30 minutes and the supernatant loaded onto a 5 
ml HisTrap HP column. The column was washed with 15 CV His. Buffer C and eluted 
with a linear gradient of His. Buffer D (50 mM Tris, pH 8.0, 0.5 M NaCl, 0.5 M imidazole) 
to 100% over 27 CV at a flow rate of 3 ml/min. Peak fractions were identified by SDS-
PAGE and dialyzed against SEC buffer (50 mM HEPES, pH 7.0, 100 mM NaCl, 0.1 mM 
TCEP). The dialyzed sample was run on a Superdex 75 16/60 pg column that had been 
equilibrated with 1.5 CV SEC buffer and a single peak was observed. Peak fractions were 
pooled, flash frozen in liquid N2, and stored at -80 °C. Concentration was determined by 
measuring absorbance at 280 nm and using an extinction coefficient of 16,960/M*cm. 
 
pETRP1B-GB1-TEV-YbtE was transformed into E.coli BL21 (DE3) cells and grown in 
LB with 50 µg/ml kanamycin at 37 °C to an OD of 0.6. IPTG was added to 0.5 mM to 
induce protein expression and growth continued at 18 °C for 16 hours before harvesting. 
Cell pellets were resuspended in YbtE lysis buffer (50 mM Tris, pH 8.0, 0.5 M NaCl, 20 
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mM imidazole, 2 mM PMSF, 1 mg/ml lysozyme) and lysed using a French pressure cell at 
18,000 psi. DNase I was then added to the lysate to 20 µg/ml and incubated on ice for 15 
minutes. The lysate was clarified by centrifugation at 26,900xg for 30 minutes. The 
supernatant was loaded onto a 5 ml HisTrap HP column using a peristaltic pump, washed 
with 30 ml His. Buffer A, and eluted with a linear gradient to 100% His. Buffer B over 20 
CV at a flow rate of 2 ml/min. Peak fractions were identified by SDS-PAGE, pooled, 
concentrated using a 30K MWCO centrifugal filter (Millipore), and loaded onto a Superdex 
75 16/60 pg column that had been equilibrated with 1.2 CV NMR buffer. Peak fractions 
were identified by SDS-PAGE and pooled. TEV protease was added to cleave the GB1 tag 
and the pool dialyzed against 50 mM Tris, pH 8.0, 0.1 M NaCl, 2 mM EDTA at 4 °C 
overnight. The dialyzed sample was run on a Superdex 75 16/60 pg column that had been 
equilibrated with 1.2 CV NMR buffer. Fractions containing YbtE were identified by SDS-
PAGE, pooled, and stored dilute at 4 °C. Concentration was determined by measuring 
absorbance at 280 nm and using an extinction coefficient of 52,370/M*cm. 
 
His6-tagged Sfp was overexpressed in E. coli BL21 (DE3) cells and grown in LB with 50 
µg/ml kanamycin at 37 °C to an optical density of 0.6. IPTG was added to a final 
concentration of 0.5 mM to induce protein expression and growth continued for an 
additional 4 hours. Cells were harvested and the cell pellet was resuspended in Sfp lysis 
buffer (50 mM Tris, pH 7.4, 0.5 M NaCl, 20 mM imidazole, 0.4 mg/ml lysozyme, 2 mM 
PMSF) and lysed using a French pressure cell at 18,000 psi. DNaseI was added to the lysate 
to 20 µg/ml and incubated on ice for 15 minutes. The lysate was clarified by centrifugation 
at 26,900xg for 30 minutes. The supernatant was loaded onto a 5 ml HisTrap HP column 
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using a peristaltic pump, washed with 30 ml His. Buffer A, and eluted with a linear gradient 
to 100% His. Buffer B over 20 CV at a flow rate of 2 ml/min. Peak fractions were identified 
by SDS-PAGE and pooled. The pooled fractions were run on a Superdex 75 16/60 pg 
equilibrated with 1.2 CV 50 mM Tris, pH 8, 100 mM NaCl. Fractions containing Sfp were 
identified by SDS-PAGE, concentrated to 160 µM, and separated into 100 µl aliquots. 
Aliquots were flash frozen in liquid N2 before storing at -80 °C. Concentration was 
determined by measuring absorbance at 280 nm and using an extinction coefficient of 
28,880/M*cm. 
 
Phosphopantetheinylation of apo ArCP 
Apo ArCP was phosphopantetheinylated in vitro in multiple 0.5 ml reactions containing 
50 µM apo ArCP, 75 mM Tris, pH 7.5 at 22 °C, 10 mM MgCl2, 2 mM DTT, 250 µM 
Coenzyme A trilithium salt (Sigma), and 500 nM of the PPtase Sfp. Reactions were 
incubated at 30 °C for 4 hours and then combined and concentrated. Holo ArCP was then 
purified by size exclusion chromatography on a Superdex 75 16/60 pg that had been pre-
equilibrated with 1.2 column volumes NMR buffer. Fractions containing holo ArCP were 
identified by SDS-PAGE, pooled, and stored dilute at 4 °C.  
 
MALDI-TOF Mass Spectrometry Measurements 
All MALDI-TOF experiments were performed using a Voyager DE-STR (Applied 
Biosystems) instrument in linear mode. Sinapic acid (10 mg/ml in 50% acetonitrile/0.1% 
trifluoroacetic acid (TFA)) was used as a matrix. Samples were prepared by 50-fold 
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dilution into 0.1% TFA. Masses were calibrated using the Protein Calibration Standard 1 
(Bruker) with standards ranging from 5734.51-16952.30 Da. 
 
NMR Experiments 
All samples were prepared in NMR buffer with 90% H2O/10% D2O at a final concentration 
of 0.3-0.4 mM with DSS for internal referencing.  
 
To determine the optimal conditions for ArCP long term solubility, we performed a buffer 
screen with an incomplete factorial design approach35. This approach allowed us to 
effectively sample a large number of solution conditions in a small number of experiments 
(48). The long-term solubility of ArCP was tested at 8 pHs (5.0, 5.5 (sodium acetate), 6.0, 
6.5, 7.0 (sodium phosphate or HEPES when containing magnesium), 7.5, 8, and 8.5 
(TrisHCl), all buffer at 100 mM), 5 salt types (NaCl, KCl, MgCl2, MgSO4, and Na2SO4), 5 
salt concentrations (10 mM, 50 mM, 100 mM, 200 mM, and 300 mM), and 4 additives 
(BSA 20 ฀M, Arg/Glu at 25 or 50 mM, and no additive). To test the solubility, 900 nl 
hanging drops (600 nl 150 µM ArCP in 20 mM HEPES, pH 6.72, 150 mM NaCl, 1 mM 
DTT and 300 nl test solution) were set up in a 96 well plate with 100 µl of the 
corresponding test solution in the well. Drops were imaged after 19 days using a Rock 
Imager (Formulatrix) and scored based on visible precipitation. The scores were analyzed 
using the procedure of Ducat and collaborators35. The screen indicated that ArCP was most 
soluble in buffers with high pH (7.5 or 8) and poorly soluble in buffers with a pH below 7.  
Initial NMR experiments were thus performed in a buffer with a pH of 7.5. However, the 
pH of the buffer was lowered to 6.8 to allow for detection of two resonances that are 
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otherwise invisible due to solvent exchange line-broadening. At lower pH, the solubility of 
ArCP is unsuitable for NMR studies. Thus, the pH of 6.8 is a compromise between protein 
solubility and spectroscopic properties. 
 
All spectra were collected at 25 °C on a 600 MHz Bruker Avance III spectrometer equipped 
with a QCI cryoprobe. Unless otherwise noted, 2D-HN-HSQC spectra were recorded with 
spectral widths of 16.019 ppm for proton, centered at 4.696 ppm, and 26 ppm for nitrogen, 
centered at 117 ppm, with a data matrix of 1024 × 128 complex points. A recycling delay 
of 1 s was used and 16 scans were accumulated, amounting to a measurement time of 1 
hour 20 minutes. Each spectrum was linear predicted and zero-filled to a final size of 2048 
(1H) × 256 (15N) points.  
 
Assignment of apo ArCP was performed using a 0.3 mM 15N,13C-labeled sample and a 
standard suite of triple resonance experiments25,26, namely HNCA (8 scans, 2048 (1H, 
16.019 ppm at 4.705 ppm) × 28 (15N, 35 ppm at 118 ppm) × 64 (13C, 35 ppm at 53 ppm) 
complex points, 19.5 hrs), HNCO(8 scans, 2048 (1H, 16.019 ppm at 4.705 ppm) × 20 (15N, 
118 ppm at 4.705 ppm) × 50(13C, 173 ppm at 4.705 ppm) complex points, 11 hrs),  
HNCACO (8 scans, 2048(1H, 16.109 ppm at 4.705 ppm) × 23 (15N, 35 ppm at 118 ppm) × 
50 (13C, 15 ppm at 173 ppm) complex points, 2 days 2.5 hrs), HNCOCA (32 scans, 2048 
(1H, 16.019 ppm at 4.705 ppm) × 29 (15N, 35 ppm at 118 ppm) × 75(13C, 35 ppm at 53 ppm) 
complex points, 1 day 23.5 hrs), HNCACB (40 scans, 2048 (1H, 16.019 ppm at 4.705 ppm) 
× 20(15N, 35 ppm at 118 ppm) × 75(13C, 70 ppm at 38 ppm) complex points, 3 days 11 hrs). 
All 3D spectra were linear predicted once and zero-filled to the nearest power of two. 
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3D-NOESY-HN-HSQCs (16 scans, 2048 (1H, 16.019 ppm at 4.696 ppm) × 40 (15N, 26 
ppm at 117 ppm) × 120 (1H, 11 ppm at 4.696 ppm) complex points, mixing time of 90 ms, 
4 days 12 hrs) were recorded for 15N samples of apo, holo, and loaded ArCP. The 
assignment of apo ArCP was transposed to the signals of holo and loaded ArCP when the 
nOe cross-peaks enabled unambiguous identification. All 3D spectra were linear predicted 
once and zero-filled to the nearest power of two. 
 
All NMR spectra were processed using NMRPipe and analyzed using CARA. Intensity 
measurements were made using the batch integration mode in CARA and plotted and 
analyzed using MATLAB. 
 
Monitoring ArCP Loaded with Salicylate by NMR 
Observation of loading was performed by first adding salicylic acid (100 mM stock in 
NMR buffer, pH 6.80) to 2 mM to holo ArCP and recording an HN-HSQC to verify lack 
of interaction (Figure 2-3). ATP (100 mM stock in NMR buffer, pH 6.80) was then added 
to 2 mM and an HN-HSQC recorded to verify lack of interaction (Figure 2-3). YbtE (in 
NMR buffer) was then added to 100 nM and a series of HN-HSQCs (8 scans, 1024(1H, 
16.019 ppm at 4.696 ppm) × 128(15N, 26 ppm at 117 ppm) complex points, 40 minutes) 
recorded. Time points reported for the time course of loading were chosen as the midpoint 
of each spectrum (Figure 2-4).  
 
Monitoring Hydrolysis of Loaded ArCP by NMR 
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Uncatalyzed and SrfTEII-catalyzed hydrolysis were monitored using loaded ArCP freshly 
purified by size exclusion chromatography (using a Superdex 75 16/60 pg column 
equilibrated with 1.2 CV of NMR buffer). The uncatalyzed hydrolysis of purified loaded 
ArCP was monitored by collecting HN-HSQCs over the course of 15 days. Time points in 
Figure S4 correspond to the starting time of each spectrum. For SrfTEII catalyzed 
hydrolysis, the buffer of SrfTEII was first exchanged from HEPES to ACES by repeated 
dilutions and concentrations in NMR buffer using an Ultracel-3K (Millipore) centrifugal 
filter until a 1600-fold buffer exchange had been achieved. SrfTEII was added to a final 
concentration of 500 nM, and a series of HN-HSQCs was collected and analyzed in the 
same manner as described for the loading reaction (Figure 2-5). SrfTEII is a promiscuous 
type II thioesterase, routinely used to hydrolyze NRPS thioester substrates.24 
 
Regeneration of Loaded Carrier Proteins Versus Amide and Ester Mimics of Loaded 
Carrier Proteins 
Our method complements existing protocols for studying loaded CPs. In order to avoid 
hydrolysis, it is possible to prepare carrier proteins loaded with their substrates but with 
ester and amide bonds instead of labile thioester bonds. To do so, the (protected) substrate 
is first coupled to ethylenediamine (to make amide mimics) or ethanolamine (to make 
esters). Second, chemical synthesis is used to produce derivatives of pantetheine.36 Next, 
the pantetheine derivatives are incubated with three enzymes, Pank, Ppat, and DpcK, to 
produce CoA derivatives36,37. Finally, incubation with a phosphopantetheine transferase 
(e.g. Sfp) leads to a carrier protein loaded with its substrate via an amide (or ester) bond in 
place of a thioester bond38–40. The enzymatic reactions can be combined in a one-pot 
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reaction36. Clearly, for studies of substrate monomers, our method using in situ 
regeneration of loaded CPs is both easier and cheaper. Carrier proteins are simply 
incubated with substrates and catalytic amounts of adenylation domains. Further, carrier 
proteins are loaded with their substrates via native thioester bonds and the influences of 
amide or ester bonds need not be considered. However, our method may be ill-suited for 
studies of CPs loaded with complex intermediates (e.g. polypeptides instead of amino acid 
monomers), as generating the loaded intermediate in situ would require adding other 
catalytic domains in addition to adenylation domains. Thus, the combined catalytic 
efficiency of multiple enzymes would have to overcome hydrolysis in order to regenerate 
a CP loaded with the appropriate intermediate. Moreover, this procedure could produce a 
mixture of monomer and intermediate loaded carrier proteins, hindering analysis and 
interpretation. Thus, for studies of CP loaded with intermediates, non-hydrolysable analogs 
are most likely best suited, whereas studies of CPs loaded with monomeric substrates may 






Figure 2-1. (A) Reactions catalyzed by YbtE and SrfTEII and their time-course (A1, A2, 
respectively), here monitored by the signal of Ser52, the phosphopantetheinylation site. (B) 
Signal of Ser52 during the loading reaction (B1-B4) and following the addition of SrfTEII 






Figure 2-2. (A) Overlay of holo (red) and salicylate loaded (blue) ArCP HN-HSQCs. 
Signals with CSP greater than 1 standard deviation above the median are indicated. Insets 
show zooms on the signals of (B) Ser52, (C) Ile53, and (D) Ala77. (E) Mapping the 
residues with significant CSPs on the secondary structure of ArCP shows two distinct 





Figure 2-4. Time course of the loading reaction monitored with the signals of S52. The 
signal of holo ArCP (open circles) decreases over time as the signal of loaded ArCP 





Figure 2-5. Time course of substrate hydrolysis catalyzed by SrfTEII showing the rapid 
decay of the signal of S52 in loaded ArCP (filled circles) with a corresponding increase 




Figure 2-6. Representative time course of uncatalyzed hydrolysis of loaded ArCP, 
showing the decay of the signal of loaded ArCP for residue S52 (open circles) and 






Figure 2-9. Chemical Shift Perturbation comparing chemical shifts of holo-ArCP and 








 where Δδi is the chemical shift difference between the 
two species for nucleus i. The horizontal solid line indicates the median (0.009 ppm) and 
the dashed line indicates one standard deviation above the median (0.036 ppm). Residues 




Chapter 3-Solution structure of a nonribosomal peptide synthetase carrier protein 
loaded with its substrate reveals transient, well-defined contacts 
 
This chapter was published with minor modification in The Journal of the American 




 Nonribosomal peptide synthetases (NRPSs) are microbial enzymes that produce a wealth 
of important natural products by condensing substrates in an assembly line manner. The 
proper sequence of substrates is obtained by tethering them to phosphopantetheinyl arms 
of holo carrier proteins (CPs) via a thioester bond. CPs in holo and substrate-loaded forms 
visit NRPS catalytic domains in a series of transient interactions. A lack of structural 
information on susbtrate-loaded CPs has hindered our understanding of NRPS synthesis. 
Here, we present the first structure of an NRPS aryl carrier protein loaded with its substrate 
via a native thioester bond, together with the structure of its holo form. We also present the 
first quantification of NRPS CP backbone dynamics. Our results indicate that prosthetic 
moieties in both holo and loaded forms are in contact with the protein core, but they also 
sample states in which they are disordered and extend in solution. We observe that substrate 
loading induces a large conformational change in the phosphopantetheinyl arm, thereby 
modulating surfaces accessible for binding to other domains. Our results are discussed in 




Nonribosomal peptide synthetases (NRPSs) are enzymatic systems found in bacteria and 
fungi responsible for the production of a myriad of secondary metabolites. These systems 
are capable of generating exceptionally complex and diverse natural products from simple 
starting materials such as amino and aryl acids by utilizing a modular architecture. Multiple 
modules are arranged in an assembly-line fashion to comprise the full synthetase, an 
organization also encountered in related fatty acid syntheases (FASs) and modular 
polyketide syntheases (PKSs)20,41–48. Each module within an NRPS is comprised of at least 
three core domains whose combined action leads to the selection, activation, and 
incorporation of a single small molecule into the growing peptide1,49,50. NRPS modules 
select starting materials from a pool of hundreds of small molecules including the 20 
standard L-amino acids, small aryl acids, and D-amino acids. Assembling these small 
molecules in a combinatorial fashion creates the potential to generate enormous chemical 
and functional diversity. A central aspect of this successful strategy is the covalent 
tethering of chemical substrates to the assembly line, which occurs through so-called 
carrier proteins. 
Each module within a NRPS is typically composed of at least an adenylation (A) domain, 
a condensation (C) domain, and a thiolation domain, also called a carrier protein (CP). CPs 
must first be activated via attached of a 4’-phosphopantetheine (PP) moiety to a conserved 
serine by a phosphopantetheinyl transferase51. The PP provides a thiol by which activated 
monomers and intermediate products are covalently tethered to the synthetase. A domains 
load the substrates onto CPs by catalyzing two distinct reactions. First, the select the amino 
or aryl acid to be incorporated and activate it using ATP via formation of a high energy 
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acyl-adenylate. Second, they loaded the activated monomer onto CPs via formation of a 
thioester with the PP. C domains then catalyze amide bond formation between products 
loaded on adjacent CPs, passing intermediates from an upstream donor CP to a downstream 
acceptor CP and extending the peptide by a single monomer. After the final monomer is 
incorporated, a thioesterase domain found in the final module releases the peptide via 
hydrolysis or macrocyclization. During synthesis, NRPS carrier proteins must interact with 
at least three different catalytic domains: a PPTase, an A domain, and one or more C 
domains. Crystallographic and nuclear magnetic resonance (NMR) studies have indicated 
that these interactions do nor occur within the confines of a rigid assembly of NRPS 
domains but through a succession of transient interactions involving a dynamic quarternary 
structure9,10,14,18,52,53. Understanding the role the chemical modifications of CPs play in 
orchestrating this series of transient protein-protein interactions is key to elucidating the 
molecular mechanism of NRPS synthesis. 
Progress in understanding the molecular influences of PP and substrates on the function of 
carrier proteins has been impeded by the lack of structural information on substrate-loaded 
NRPS carrier proteins. There are several NMR and crystal structures of apo- and holo-CPs 
either isolated or together with other NRPS domains2,4,5,11,14,18,50,54–58. Of these, the only two 
solution structures of isolated holo carrier proteins have produced contradictory results 
with respect to the influence of the PP moiety. In the first system, PP was found not only 
to bind to its CP but also to dramatically influence conformational fluctuations5. In the 
second study, the protein core of CP was thought to interact only weakly, if at all, with the 
PP, leading to the conclusion that phosphopantetheinylation does not affect the carrier 
protein in a relevant manner4. Perhaps more importantly, there are currently no structures 
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available of substrate-loaded CPs from an NRPS and it remains unclear whether the 
substrate is simply tethered on an unstructured PP arm or if it interacts with its carrier 
protein. Lack of success in studying structures of loaded carrier proteins results in part from 
rapid hydrolysis of the thioester bond, so we recently proposed a means to bypass this 
limitation for monomeric substrates8. Determining if the loaded substrate directly interacts 
with the protein core of a CP or remains unbound will shape our understanding of the role 
it plays in directing protein-protein interactions. 
In order to study the influence of substrate loading on the structure of a CP, we determined 
the solution structures of the aryl carrier protein (ArCP) from yersiniabactin synthetase in 
its holo and substrate-loaded forms. Yersiniabactin (Figure 3-1E) is an iron chelator and 
virulence factor for Yersinia pestis, the causative agent of the bubonic plague, and its 
biosynthesis has been extensively characterized22,59–64. The yersinibactin synthetase system 
is comprised of the stand-alone A domain YbtE, the multidomain proteins HMWP2 (Figure 
3-1A) and HMWP1, and the reductase YbtU. ArCP is the first carrier protein involved in 
yersiniabactin synthesis. It composes the N-terminal 100 residues of HMWP2, which also 
contains two cyclization domains (Cy1 and Cy2), an adenylation domain (A), two peptidyl 
carrier proteins (PCP1 and PCP2), and an epimerization domain (E) (Figure 3-1A). 
Cyclization domains are related to condensation domains yet catalyze a cyclodehydration 
in addition to condensation. As a starter carrier protein, ArCP has a relatively simple 
lifecycle. Following activation of carrier proteins to holo forms, YbtE loads ArCP with 
salicylic acid while the A domain of HMWP2 loads PCP1 with cysteine (Figure 3-1B). 
Cy1 then catalyzes peptide bond formation and cyclization between the substrates loaded 
on ArCP and PCP1, regenerating holo-ArCP and producing PCP1 now loaded with a 2-
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hydroxyphenylthiazoline moiety (Figure 3-1C). Two forms of ArCP communicate with 
catalytic domains during synthesis: holo-ArCP is a substrate for YbtE and a product for 
Cy1, where ArCP loaded with salicylate (hereafter referred to as ‘loaded-ArCP’) is a 
product of YbtE and a substrate for Cy1. 
We have previously established a method for analysis of ArCP loaded with salicylate in its 
native thioester form by nuclear magnetic resonance spectroscopy8. The method exploits 
the non-invasive nature of NMR and isotope editing to allow for sustained measurements 
on loaded-ArCP. Loaded-ArCP is generated in situ and the appropriate concentration of 
substrates and adenylation domain, Sal and YbtE, ensure that the regeneration of loaded-
ArCP outperforms hydrolysis without influencing the chemical shift perturbations (CSPs) 
observed in the susbtrate-loaded form. We found that these CSPs occur along multiple 
distinct structural elements of the core of the protein. However, CSPs cannot differentiate 
among a direct interaction with the substrate, structural changes in the ArCP, a modulation 
of protein dynamics, or some combination of these effects. Here, we present the solution 
structures of ArCP in the holo and salicylate-loaded forms together with a characterization 
of the dynamics of holo and loaded-ArCP, including the PP. We show that holo-ArCP has 
a transient yet well-defined interaction with the PP and that the protein core of ArCP has a 
direct interaction with loaded salicylate, and we discuss the role these observations may 
play in influencing protein-protein interactions in NRPS systems. 
 
Results and Discussion 
Acyl, aryl, and peptidyl carrier proteins play a central role in PKSs, FASs, and NRPSs as 
they shuttle substrates between various catalytic sites during synthesis. In the past few 
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years, various structural and functional studies have suggested that NRPSs are not rigid 
assemblies but are subject to inter-domain dynamics. Notably, rather than simply swinging 
the phosphopantetheinyl arm between active sites, the entire carrier protein is expected to 
visit partner domains in a series of transient domain interactions. Understanding the 
biosynthesis of all associated products thus requires an understanding of the molecular 
parameters that modulate these successive transient domain interactions9,14,18,52,53. Here, we 
will describe how both the phosphopantetheinyl arm and its tethered substrate interact with 
the core of an NRPS aryl carrier protein in its holo and substrate-loaded form. We found 
that although these interactions are well-defined they are nevertheless transient as a 
substrantial population of both holo- and loaded-ArCP possesses prosthetic groups subject 
to large amplitude motions. Our results provide novel insights into interactions between 
carrier proteins and PP and tethered substrates, and our observations will be discussed 
within the framework of domain interactions. 
Structures of holo- and loaded-ArCP 
Holo-ArCP and loaded-ArCP both display the right-handed helical bundle fold typical of 
carrier proteins2,65,66 (Figure 3-2A-D). This fold consists of three long helices with an up, 
down, down arrangement (α1, A19-E31, α2, S52-K64, and α4, L80-M87) and an 
additional shorter helix (α3, L71-A76). Here, secondary structure boundaries are defined 
as observed in the mean structure of holo-ArCP. The post-translational modification site, 
S52, is located at the N-terminal end of α2. In ArCP, the four helices are packed 
predominantly by a hydrophobic core substantiated with aromatic interactions (F62, W83, 
Y67, W58, and W61 partially). In addition, in holo-ArCP, a salt bridge can form between 
E31 and R54 (α1/α2) although R54 may also interact with D51 with different rotamers. 
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α1 and α2 are linked by loop1, which is well-defined (Figure 3-3) and features a single-
turn helix, αI (L45-A48). Loop1 is held in place by a number of hydrophobic interactions 
with α1, α3, and α4 and likely with an ionic interaction between E41 and R25 in the holo 
form. These interactions allow for a large number of distance constraints to be detected, 
which anchors loop1 to the helical bundle core of ArCP in the NMR ensemble. α3 lies in 
between loop 2 (G66-T70) and the very short loop 3 (A77-T79). Overall, ArCP in both the 
holo and loaded forms adopts a well-defined and compact protein fold. 
A large number of NOESY cross-peaks revealed direct contacts between PP and ArCP in 
holo-ArCP and between PP, Sal, and ArCP in loaded-ArCP. In holo-ArCP, a total of 50 
cross-peaks involving PP could be assigned unambiguously (Figures 3-4, 3-5, and 3-10). 
They include 14 nOe’s within the PP arm. These nOe’s have the same sign as the source 
peaks (so-called diagonal signals in NOESY experiments) which demonstrates that the PP 
arm is subject to the same molecular tumbling as the carrier protein. In addition, 36 nOe’s 
between the protein core and PP could be identified. These nOe’s denote a contact between 
PP and ArCP. Together, these cross-peaks were used as constraints to define the 
conformation of PP and to position it on the surface of ArCP. Similarly, NOESY cross-
peaks permitted the determination of the structure of PP tethered to salicylate in loaded-
ArCP (Figures 3-6, 3-7, 3-8, 3-9, and 3-10). Here, 12 strong and unambiguous nOe’s were 
observed between loaded-ArCP and Sal and 8 with PP. In addition, 11 constraints could be 
determined within the Sal-PP moiety. As for holo-ArCP, the NOESY cross-peaks are 
indicative of a stable, well-defined interaction between loaded-ArCP and its prosthetic 
group.  
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Substrate loading alters the conformation of the PP arm in a dramatic manner and modifies 
the surface of the protein sustained by α2, α3, and nearby regions. In holo-ArCP, the 
phosphopantetheinyl arm is extended and docks on ArCP along α2 on one side and α3 on 
the other side (Figure 3-2A,B). Such a conformation masks a large area of the solvent-
exposed surface of α2 and α3. This surface involves residues S52, I53, M56, and L59 on 
α2, and L71, R72, and Y75 on loop 2 and α3. Upon substrate loading, the 
phosphopantetheinyl arm adopts a curled conformation that accommodates salicylate 
binding (Figure 3-2, C,D, and F). Sal binds at the surface of ArCP in a region defined by 
the N-terminal end of α2, the C-terminal end of loop 1, and the C-terminal end of α3. 
Together, Sal and PP cover a surface involving residues L50-I53, M56, R72, Y75, A76, 
and I46. Hence, the change of conformation induced by tethering of salicylate exposes a 
region previously covered by PP in holo-ArCP and masks a new region of ArCP. Both 
regions are involved in domain communication and the significance of this alteration in 
surface access will be discussed within the framework of domain interactions below. 
Comparison of the protein cores of holo- and loaded-ArCP reveals that subtle changes 
occur upon substrate loading. As underlined, the overall core adopts the same fold in holo- 
and loaded forms. Three helices, α1, α2, and α4, are slightly shorter after substrate loading. 
Accordingly, there is a slight variation in the relative distances between helices 1, 2, and 
3. The N-terminal end of α2 moves towards α1 and away from α3, in a manner that 
accommodates substrate docking in loaded-ArCP (Figure 3-2B and D). While doing so, α2 
rotates slightly and the phosphate group on S52 is moved towards the outside of the protein 
(perhaps best seen in Figures 3-10 and 3-11), and the helices in the bundle become more 
parallel to one another. Of note: in loaded-ArCP, the angles of residues in αI are interpreted 
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as helical by some software packages (molmol, see e.g. Figure 3-12C) but not by others 
(PyMOL, see Figure 3-2C and D). The spatial arrangement of the residues involved is 
however rather well-maintained in holo- and loaded-ArCP (Figure 3-2E). A major 
difference between the NMR ensembles of holo-ArCP and loaded-ARCP lies in a change 
of conformation of loop 1, between L41 and N46 (Figure 3-2E). This region packs against 
the helical bundle with hydrophobic interactions towards the core, but also with 
interactions involving side-chains of α1 and α4 that are more peripheral. In holo-ArCP, 
the latter provide more NMR constraints while in the loaded form constraints with the core 
dominate. This change in conformation shifts the mean positions of the amide proton of 
E41 by 4 angstroms. As a consequence, the ionic interaction previously mentioned between 
E41 and R25 can only occur in the holo form. Loop 1 has been shown to be involved in a 
number of interactions with NRPS catalytic domains5,10,11,54,67–69 and its change in 
conformation is discussed further below. 
Dynamics in the ArCP core 
The protein cores of holo- and loaded-ArCP are mainly rigid on fast time-scales but 
undergo local conformation fluctuations at slower time-scales. To asses the dynamics of 
holo- and loaded-ArCP, we measured the nitrogen longitudinal (Figure 3-13A) and 
transverse (Figure 3-13B) relaxation rates (R1 and R2, respectively) as well as the 
heteronuclear NOE between amide protons and nitrogens (HN-NOE, Figure 3-13C). R2 is 
sensitive to both motions in picosecond and nanosecond time scale and in microsecond or 
slower time scales. R1 is sensitive exclusively to picosecond to nanosecond motions. HN-
NOE is a direct reporter of picosecond to nanosecond fluctuations in bond orientations. We 
applied the Lipari-Szabo formalism70 as developed by Palmer and co-workers71 and as 
  47 
implemented by Fushman and co-workers72,73 to obtain order parameters, S2, that provide 
a measure of the amplitude of ps-ns motions (a value of 1 indicates rigidity and 0 denote 
complete disorder). Figures 3-13D and 3-14 reveal that all helices and a large part of the 
connecting loops are relatively rigid for both forms and only a few selected residues display 
increased flexibility. They are L34 and T35 in the beginning of loop 1, D51, the residue 
preceding the phosphopantetheinylation site, and R68 and L69, both in loop 2. No fewer 
than nine studies reported flexibility in the N-terminal half of loop 1 in FAS and PKS acyl 
carrier proteins (ACPs)74–82. We speculate that such flexibility may be required to achieve 
different interactions with different NRPS partner domains. The position of L34 (i-18 with 
respect to the conserved serine) was found to be at the interface between an adenylation 
domain and a related aryl carrier protein (EntB)10. 
D51 stands out as the single residue with marked fast dynamics at the end of loop 1 in both 
holo and loaded forms (Figure 3-13D). This is a rather critical observation as D51 is the 
predecessor of the PP site, a position that has been shown to be actively involved in many 
domain interactions10,11,14,18,56,57,67,68 and even hypothesized to be participating in enzymatic 
activity67, so this position must have access to many conformations to satisfy its role in 
these protein interactions. Upon re-inspecting previously reported relaxation reports and 
order parameters, we found that this position is flexible in five ACPs76–82. This conserved 
flexibility likely reflects the versatile role that the position preceding the PP site plays 
during synthesis. 
Fast internal motions have also been detected in the region encompassing R68 and L69 
(loop 2) in FAS and PKS ACPs. Flexibility has been consistently probed in loop 274–76,78,79,82, 
sometimes extending to the adjacent α380,81. α3 has often been found to be subject to 
  48 
conformational exchange and its conformation as well as its relative orientation are 
modulated upon interactions with substrates and partner domains5,74,75,79. The conserved 
flexibility of loop 2 likely permits modulation of the relative orientation between helices 
α2 and α3.  
Overall, substrate loading does not affect the flexibility of ArCP in a dramatic manner. 
Nevertheless, comparison of order parameters indicates a trend for a rigidification at ps-ns 
time-scales for a few residues. The small amplitude of these effects, however, prevents us 
from commenting on their significance. 
Slower conformation fluctuations (µs) increase the magnitude of R2 for two groups of 
residues (Figure 3-13B, color coded in Figure 3-14A and B). A18, A19, and D20 are 
located at the N-terminal end of α1 and Q37, H40, E42, S43, and L45 are all in the center 
of loop 1, up to the single turn helix, αI. All residues display Rex in the Model Free analysis 
(Figure 3-15). These two groups are remote in the structures of ArCP and these fluctuations 
likely reflect separate events. 
The conformational fluctuations observed in loop 1 are likely relevant to ArCP’s activity. 
Conformational exchange has been detected in corresponding regions of FAS and PKS 
ACPs76,82 and other regions of loop 180,81,83. Most strikingly, the two residues that display 
the largest R2 rates are H40 and E42 that flank E41 (Figure 3-14A and B). E41 could not 
be detected, presumably because its NMR resonances have been broadened by exchange 
beyond detection. We mentioned previously that E41 can form a salt bridge in holo-ArCP 
but not in loaded-ArCP because the surrounding region of loop 1 changes conformation 
upon substrate loading. We observe an overall reduction of Rex upon substrate loading, 
indicating that the substrate affects related conformational fluctuations (Figures 3-13B and 
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3-15). Indeed, salicylate docks in the vicinity of αI, which signals the end of the malleable 
region and the docking of Sal may modulate the dynamics of loop 1. In summary, the 
change in conformation that we observed when comparing holo- and loaded-ArCP 
structures results from a change in conformational equilibria and is not a static effect. In 
this context, the flexibility of T35 and L34 discussed above may reflect a hinge in this 
region, used to provide malleability to the region encompassing Q37-L45. Various residues 
in loop 1 have been shown to interact with NRPS catalytic domains5,10,11,54,67–69 
Transient interactions between ArCP and its prosthetic groups 
Our data reveal that, although they are well-defined, the interactions we see between ArCP 
and its prosthetic groups are transient in nature. Our relaxation data indicate that the NMR 
signals of PP reflect an extreme amount of motional averaging, characteristic of disorder 
(Figure 3-13, A, B, and C). However, NOE’s between ArCP and its prosthetic moieties as 
well as NOE’s within PP with the same sign as those of the protein indicate that PP is 
bound to ArCP. Together, these observations indicate an average of NMR parameters84 due 
to an equilibrium between a bound form of holo-ArCP, b-holo-ArCP, and a form in which 
PP does not bind and is disordered, u-holo-ArCP (unbound). Likewise, loaded-ArCP exists 
in both bound and unbound forms. 
The detection of positive NOE’s with signals that seemingly display high motional 
averaging is reminiscent of the transferred NOE’s that occur for small molecules binding 
to a large protein85–90. The detection of NOE’s between PP and ArCP through signals of the 
unstructured form of PP is a special case of population averaged NOE’s in which the NOE 
of u-holo-ArCP is zero. Similar effects have been discussed for NOE’s in protein cores and 
even for E. coli ACP77,91. Our results indicate that holo-ArCP and loaded-ArCP are subject 
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to equilibria between bound and unbound forms (Figure 3-14A and C). Further studies are 
necessary to characterize the populations and time-scales of these equilibria. 
In addition to our investigation of ArCP’s flexibility and conformational fluctuations, we 
have observed signals indicative of a minor conformer of ArCP in both holo and loaded 
forms. Similar observations have been mode for a PCP5 and many PKS and FAS 
ACPs74,75,78–81,83,91,92. In one study, the second conformer was shown to involve a second 
binding site for the PP arm and was accompanied by alterations in α375. We observe a 
second set of signals for PP in holo-ArCP and loaded-ArCP and a similar scenario cannot 
be excluded for ArCP. A limited chemical shift perturbation (Figure 3-16) indicates that 
these conformers are likely subject to subtle changes in conformations and do not belong 
to an unfolded or unfolded-like state. Further studies are needed to characterize these minor 
conformers.  
Implications for domain communication 
All our observations can be revisited within the context of domain interactions and catalytic 
steps that occur during biosynthesis. Following post-translational modification, ArCP 
interacts with the adenylation domain YbtE to harvest salicylate as well as with the 
cyclization domain Cy1 to catalyze the condensation of salicylate with cysteine22,23. In this 
chain of events, holo-ArCP is the substrate of YbtE and loaded-ArCP is its product. 
Conversely, loaded-ArCP is the substrate for Cy1 and holo-ArCP is a product of Cy1. 
As noted above, interactions between the core of the protein and the tethered salicylate 
alter the conformation of the PP between holo- and loaded-ArCP. This change in PP 
conformation in turn alters the electrostatic surface presented by loop 1 and helices α2 and 
α3. Loop 1, α2, and α3 are all involved in binding with other domains and altering the 
  51 
solvent exposed surfaces as described necessarily modulates domain affinities. Indeed, 
studies of related PKS ACPs have shown that changes in surface potentials could explain 
the success or failure in ACP domain swaps in 6-deoxyerythronolide B synthase93. 
Inspection of the surface potential of ArCP reveals a positively charged region defined by 
the second half of α2, loop 2, and R72 in α3, as well as a negatively charged region 
delimited by the C-terminal end of loop 1, the beginning of α2, and part of α3 and loop 2 
(Figure 3-11). In holo-ArCP, much of the positively charged area is covered by the PP arm, 
while the negatively charged region is accessible. Upon substrate loading, part of the 
positively charged area is covered by the PP arm, while the negatively charged surface is 
obfuscated by Sal and the end of the PP arm. We hypothesize that such a dramatic 
modification of the surface potential in a region consistently involved in domain 
binding5,10,11,68,69 likely participates in modulating the binding affinity of ArCP towards its 
partner domains. 
The equilibrium between unbound and bound forms of holo-ArCP may be modulated by 
various mechanisms during interactions with adenylation domains. Like all adenylation 
domains, YbtE contains a large N-terminal sub-domain, A(N), and a smaller C-terminal 
sub-domain A(C). YbtE catalyzes two distinct steps. First, salicylate is selected and 
adenylated to produce an activated mixed anhydride Sal-AMP. Second, the thiol group of 
holo-ArCP reacts with the activated carbonyl to form a thieoster bond and, hence, to load 
ArCP with salicylate. Crystallographic and biochemical studies have shown that the 
relative orientations of A(N) and A(C) changes by about 140° during the two-step reaction, 
with an adenylation conformation AA active for adenylation and a thioester conformer AT 
responsible for thioesterification9,52. The proposed mechanism invokes a transition from AA 
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to AT upon completion of the adenylation reaction and prior to binding holo-ArCP. 
Thioesterification requires PP to be extended towards the adenylate, e-holo-ArCP,  and 
thus the relevant complex consists of e-holo-ArCP bound to AT (see figure 3-12B). Our 
observations of equilibria between bound and unbound forms of holo-ArCP raise questions 
as to whether the bound form is used during A/CP recognition and which mechanisms are 
compatible with such an equilibrium. An active participation of b-holo-ArCP would mean 
that the complex competent for thioesterification, e-holo-ArCP/AT, is obtained following 
formation of an encounter complex involving b-holo-ArCP, whereas a passive 
participation would require AT to select e-holo-ArCP through u-holo-ArCP. 
The active participation of b-holo-ArCP would relate to a mechanism that has recently been 
proposed for type II FAS ACPs upon crystallization of a type II ACP trapped in complex 
with a partner protein, FabA21. Substrates in type II ACPs are buried in the cleft between 
α2 and α3. Burkart and coworkers propose that FabA recognizes ACP with a surface that 
includes PP. Following formation of this encounter complex, the substrate is excised from 
ACP and PP extends towards the active site. In our system, this would mean that the 
adenylation domain first recognizes the surface provided by α2, α3, and PP before 
rearrangements occur to yield the final e-holo-ArCP/AT complex. 
Combined insight from existing structures and the structures described here suggest how 
the positioning of PP may influence interactions with A domains and, in turn, how this 
affects each scenario described above. Complexes of e-holo-ArCP bound to AT have been 
crystallized, notably with an aryl carrier protein closely related to ArCP, EntB-ArCP10. 
Loop 1 in EntB-ArCP interacts with A(C) at positions corresponding to residues D51, Q47, 
E42, and L34 in ArCP (Figure 3-12B), whereas α2 interacts both with A(C) at positions 
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R54 and I53 and with A(N) at positions M56, H60, and K64. A simple structure alignment 
of b-holo-ArCP onto EntB-ArCP revelas that b-holo-ArCP could maintain interactions 
with an AT domain through A(C) but not A(N) (Figure 3-12A). Thus, an encounter complex 
between AT and b-holo-ArCP would necessarily occur with a different domain organization 
than that seen in Figure 3-12B. Given the existence of dramatic reorientations between 
A(N) and A(C) when going from AA to AT, it is very like that AT maintains some 
malleability, and a complex between b-holo-ArCP and AT may be accommodated. Clearly, 
a more direct conformation selection mechanism, in which AT selects e-holo-ArCp from 
the u-holo-ArCP ensemble, would not be subject to any such constraints. 
In either unboud of bound form, ArCP can interact with A(C). This is an important 
observation given that the domain reorientation in A domains was proposed to provide a 
means of shuttling carrier proteins between binding sites10,18. If A(C) is used to shuttle holo-
ArCP towards A(N), an interaction between A(C) and ArCP such as that shown in Figure 
3-12 would likely shift the equilibrium towards b-holo-ArCP, as many conformations of 
u-holo-ArCP would be incompatible with binding. Upon reaching a conformation AT, the 
adenylation domain must then select for e-holo-ArCP. This model would correspond to a 
sequence of conformational selection events and the equilibrium between b-holo-ArCP and 
u-holo-ArCp may then be a means to ensure simultaneously an interaction between A(C) 
and ArCP (with b-holo-ArCP paying an entropic cost and opening an interaction surface) 
while maintaining access to an extended form that must be selected through the unbound 
form for catalysis. Many mechanisms are compatible with our observations and further 
investigations will be necessary to decipher the mechanism of NRPS synthesis. 
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The loaded form of ArCP in bound form prevents interaction between ArCP and A(N) but 
allows for a stable interaction with A(C). Loaded-ArCP is the product of the thiolation 
reaction, and hence loaded-ArCP must dissociate from the A domain. Inspection of Figure 
3-12C demonstrates that the curled conformation of PP in the bound form would prevent 
any functional interaction between b-loaded-ArCP and AT. Thus, b-loaded-ArCP likely 
helps ensure that NRPS synthesis moves productively to the next step. Like b-holo-ArCP, 
b-loaded-ArCP can interact with A(C). Again, this observation is compatible with A(C) 
shuttling loaded-ArCP towards the next catalytic partner, here Cy1. 
Inspection of the conformation of loop1 within the context of A/CP complex suggests that 
substrate loading may help ArCP interact with the C-terminal subdomain of YbtE. Figure 
3-12D emphasizes the changes in conformation that occur in loop 1 for holo-ArCP, loaded-
ArCP, and holo-EntB-ArCP. It is immediately apparent that loop 1 moves towards A(C) 
when comparing holo-ArCP, loaded-ArCP, and EntB-ArCP. Loop 1 simultaneously adopts 
a conformation that is increasingly open with respect to the ArCP core protein. With EntB-
ArCP representing an optimal interaction, this observation suggests that loaded-ArCP 
adopts a conformation more suitable for an interaction with A(C). Thus, the bound form of 
loaded-ArCP may affect the affinity towards A domains in two manners, first by disrupting 
interactions with A(N) and adopting a conformation incompatible with a competent 
complex, and second by promoting an interaction between ArCP and A(C) by stabilizing 
loop 1 in an open form. Substrate loading would then actively contribute to release from 
A(N) and shuttling of ArCP by A(C). Further studies are needed to probe this hypothesis. 
The bound form of loaded-ArCP likely modulates interactions with partner cyclization or 
condensation domains, while access to the extended form needed for catalysis is provided 
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by the unbound form. ArCP is the first carrier protein of the yersiniabactin synthetase and, 
as such, Sal-loaded-ArCp is exclusively a substrate-donor carrier protein. There are no 
structures of condensation domains in complex with substrate-donor carrier proteins and 
we cannot make detailed mechanistic predictions for loaded-ArCP as those we discussed 
for holo-ArCP. Fortunately, biochemical studies were conducted specifically with ArCP or 
EntB-ArCP, and they identified residues in α1, loop 1, and α3 that are necessary for 
communication with condensation domains69,94. These residues were identified through 
combinatorial mutagenesis and selection and correspond to M56, L71, Y75, as well as I53, 
A76, and N44. They span the solvent accessible surface of N-terminal α2 (I53 and M56), 
C-terminal α3 (Y75 and A76), and one residues in loop 1 (N44). Strikingly, all these 
residues interact with PP or Sal in b-loaded-ArCP. It may well be that selection was 
achieved by optimizing interactions with the tethered substrate. If so, this suggests that 
bound loaded-ArCP is used as a substrate for an encounter complex. Access to e-loaded-
ArCP through its unbound form would then be used to reach the Cy (or C) domain active 
site, which is located far from the surface of these domains. Clearly, our observations must 
be revisited once the structure of a donor ArCP in complex with a cyclization or 
condensation domain is available. 
In summary, the structures of b-holo-ArCP and b-loaded-ArCP that we have determined, 
together with our observations of equilibria between bound and free forms, set a framework 




We have presented the first solution structure of a nonribosomal peptide synthetase carrier 
protein loaded with its substrate, the backbone dynamics analysis of an NRPS carrier 
protein, and the first solution structure of an aryl carrier protein, both in holo and loaded 
forms. 
The solution structures of ArCP indicate that the phosphopantetheinyl arm interacts with 
the protein core of ArCP both in holo and in loaded forms. Substrate loading induces a 
large conformational change in the PP arm that alters the nature of the protein surface in 
the surrounding regions, which are involved in domain recognition. In holo-ArCP, PP lies 
in an extended conformation between helices α2 and α3, whereas in loaded-ArCP PP curls 
back to allow for substrate binding in a region near the phosphopantetheinylation site, 
defined by loop 1, α2, and α3. The repositioning of the PP arm modulates access to regions 
of ArCP with distinct electrostatic potentials, providing a rationale for altering the binding 
affinity of ArCP to its partner domains. 
Joint analysis of NOESY spectra and NMR spin relaxation indicate that ArCP interacts 
with its prosthetic groups in a transient yet well-defined manner. Our findings indicate that 
both holo- and loaded-ArCP undergo conformational equilibria between unbound and 
bound forms. Interactions with PP have been occasionally observed in NMR studies of 
NRPS, PKS, and FAS carrier proteins and the (well-established) motional averaging of 
NMR parameters we discussed can be applied to revisit observations made for these 
systems. 
Many molecular properties have been discussed within the context of NRPS, PKS, and 
FAS domain communication and our results suggest that the dynamics of the prosthetic 
group must be considered as well. That is, binding to carrier proteins must occur through a 
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conformational selection of unbound or bound forms, potentially with subsequent induced 
fits or conformation selection events. In addition, we have observed dynamics in the protein 
cores of holo- and loaded-ArCP that cover all time-scales, in agreement with multiple 
reports. We discussed the relevance of flexible and malleable regions in ArCP within the 
context of interactions with partner domains, with emphasis on adenylation domains. 
Notably we have found that substrate loading affects conformational fluctuations occurring 
in loop 1, a region involved in domain communication. Together, our results substantiate 
a mechanism for NRPS synthesis that relies on the interplay between chemical 
modification and modulation of molecular properties, such as dynamics and surface 




Cloning of ArCP 14-93 and Sfp into pET-Duet-1  
Sfp and GB1-TEV-ArCP14-93 were cloned into multiple cloning sites 1 and 2 of the dual 
expression vector pET-Duet-1, respectively, in two steps. The fragment coding for GB1-
TEV-14-93 was PCR amplified from pETRP1B-GB1-TEV-ArCP14-93 using primers 
ArCP_NdeI_Nterm (5’-GGAGATATACATATGCAGTACAAACTGATCC-3’) and 
ArCP_XhoI_Cterm-2 (5’-GGTGCTCGAGCCGCCTACTCAG GCGACC-3’) to generate 
a DNA fragment containing XhoI and NdeI cut sites. The PCR product and target vector 
pET-Duet1 were digested with XhoI and NdeI, gel purified, and extracted. The fragment 
coding for GB1-TEV-ArCP14-93 was ligated into pET-Duet-1 to yield pET-Duet-MCS1-
GB1-TEV-ArCP14-93. The fragment coding for Sfp-His6 was PCR amplified from 
pET24a-SfpHis6 using primers Sfp_NcoI_Nterm-2 (5’-GAAGGAGATATACCCAT 
GGAGATTTACGGAA-3’) and Sfp_EcoRI_Cterm-2(5’-
AGCGTTGAATTCGATCTCCAGTGGTGGTGGTGGTGGTGCTCCAGTAAAGCTC-
3’) to generate a DNA fragment containing NcoI and EcoRI cut sites. The PCR product 
and target vector pET-Duet-MCS1-GB1-TEV-ArCP14-93 were digested with NcoI and 
EcoRI, gel purified, and extracted. The fragment coding for Sfp-His6 was ligated into pET-
Duet-MCS1-GB1-TEV-ArCP14-93 to yield pET-Duet-SfpHis6-GB1-TEV-ArCP14-93. 
Site-directed mutagenesis using the vector pET-Duet-SfpHis6-GB1-TEV-ArCP14-93 and 
primers pET-Duet-Sfp_AddT_For (5’TGGTCTCGT ACGAAGAGCTTTTACTGGAG-
3’) and pET_Duet-Sfp_AddT_Rev (5’TGGTGGTGGTGGTGGTGCTCCA GTAAAA-
3’) was performed to correct a frame-shift mutation that occurred during cloning. The DNA 
sequence of pET-Duet-SfpHis6-GB1-TEV-ArCP14-93 was confirmed by DNA 
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sequencing. This plasmid directs production of Sfp containing a C-terminal hexahistidine 
tag and residues 14-93 of HMWP2 with an N-terminal GB1 tag followed by a hexahistidine 
tag and a TEV cleavage site. Following TEV cleavage of GB1-TEV-ArCP14-93, a GT 
sequence remains at the N-terminus of ArCP14-93.  
 
Cloning of YbtE, ArCP 14-93 (without Sfp), Sfp, their expression and purification were 
performed as previously described8.  
 
Purification of holo-ArCP Made from Coexpression with Sfp  
The purification of holo-ArCP resulting from coexpression with Sfp is identical to that 
reported for apo ArCP8 except for the following modifications. pET-DUET-SfpHis6-GB1-
TEV-ArCP14-93 was transformed into ΔEntD cells (courtesy Drs. Chalut and Guilhot, 
CNRS, Toulouse, France). Amipicillin was used instead of kanamycin. Following 
overnight cell growth at 37°C , the temperature was lowered to 18 °C when reaching an 
optical density of 0.4. At an optical density of 0.6, IPTG was added to 0.5 mM and growth 
continued at 18 °C. Cells were harvested 4-4.5 hours after induction at an optical density 
of 1.1-1.2. Following digestion by TEV protease and HisTrap purification, dithiothreitol 
(DTT) was added to a final concentration of 10 mM.  
In vitro phosphopantetheinylation of apo ArCP was performed as described previously. 
Completion of the phosphopantetheinylation reaction was confirmed by HN-HSQC. 
 
NMR Data for Assignment and Structure Determination  
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All spectra were collected at 25 °C on a 600 MHz Bruker Avance III spectrometer equipped 
with a QCI cryoprobe. All NMR spectra were processed using NMRPipe95 and analyzed 
using CARA96. Details of NMR acquisitions are described below 
To ensure long-term stability of NMR samples, samples were buffer exchanged (>125-
fold) into freshly prepared NMR buffer containing 0.05% (w/v) sodium azide by repeated 
concentration and dilution immediately prior to use. D2O was added to all samples to a 
final concentration of 10% and DSS was used for internal referencing. For samples in D2O, 
NMR buffer was prepared as described above in 99.8% D2O (Aldrich Chemistry) and the 
pH adjusted using sodium deuteroxide (40% in D2O, 99.5% D, Cambridge Isotope 
Laboratories) to a pH of 6.40 (pD=6.80).  
 
15N-Holo-ArCP used for the holo and loaded samples was generated in vitro using apo 
ArCP, purified Sfp, and unlabeled coenzyme A. The NOESY-HN-HSQC of holo-ArCP 
was run on a 520 µM sample in the standard NMR buffer containing 1 mM DTT instead 
of 500 µM TCEP. To prepare the loaded sample, salicylic acid and ATP were added to 2 
mM and YbtE added to 100 nM to 400 µM ArCP and the loading reaction monitored by 
HN-HSQC. The NOESY-HN-HSQC was begun immediately upon completion of loading. 
3D-NOESY-HN-HSQCs (16 scans, 20148 (1H, 16.109 ppm at 4.696 ppm) × 40 (15N, 26 
ppm at 117 ppm) × 120 (1H, 11 ppm at 4.696 ppm) complex points, mixing time of 90 ms, 
4 days 12 hrs) were recorded for sample of apo-, holo-, and loaded-ArCP. All spectra were 
linear-predicted once and zero-filled to the nearest power of two.   
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13C,15N apo ArCP has previously been assigned8 and its assignment was used as a starting 
point for assigning holo- and loaded-ArCP resonances. 
 
13C,15N-Holo-ArCP was generated by coexpression with Sfp such that the 
phosphopantetheine cofactor is also labeled. A first sample was prepared in buffered H2O 
to complete resonance assignments and collect dihedral angle constraints. The following 
experiments were run on a 320 µM samples in 90% H2O/10% D2O: HNCO (16 scans, 2048 
(1H, 16.019 ppm at 4.698 ppm) × 64 (15N, 26 ppm at 117 ppm) × 75 (13C, 11 ppm at 174 
ppm) complex points, 10 hrs 20 mins), HNCA (16 scans, 2048 (1H, 16.019 ppm at 4.698 
ppm) × 64 (15N, 26 ppm at 117 ppm) × 100 (13C, 30 ppm at 52 ppm) complex points, 13 
hrs 44 mins), HNCACB (32 scans, 2048 (1H, 16.109 ppm at 4.698 ppm) × 64 (15N, 26 ppm 
at 117 ppm) × 150 (13C, 60 ppm at 42 ppm) complex points, 1 day 18 hrs 14 mins), 
HNCACO (32 scans, 2048 (1H, 16.019 ppm at 4.698 ppm) × 64 (15N, 26 ppm at 117 ppm) 
× 75 (13C, 11 ppm at 75 ppm) complex points, 20 hrs 55 mins), and HcccoNH (16 scans, 
2048 (1H, 16.109 ppm at 4.698 ppm) × 28 (15N, 26 ppm at 117 ppm) × 50 (1H, 7 ppm at 
4.698 ppm) complex points, 1 day 7 hrs 25 mins). 
 
A 390 µM sample was prepared in D2O by repeated concentration and dilution in NMR 
buffer prepared in D2O until a 900-fold dilution had been achieved. This sample was used 
for aromatic side-chain resonance assignment and to collect distance constraints involving 
aliphatic and aromatic protons. The following experiments were run in D2O: 2D-
hbCBcgcdHD (192 scans, 2048 (1H, 16.1092 ppm at 4.696 ppm) × 52 (13C, 22.002 ppm at 
30 ppm) complex points, 3 hrs 18 mins) and 3D-HC-HSQC-NOESY (16 scans, 2048 (1H, 
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16.0192 ppm at 4.696 ppm) × 100 (1H, 13 ppm at 4.696 ppm) × 50 (13C, 50.0003 at 69.5 
ppm) complex points, mixing time of 90 ms, 4 days 15 hrs 29 mins). 
 
13C,15N-Loaded-ArCP was prepared by adding salicylic acid and ATP to 2 mM (final 
concentration) and YbtE to 100 nM (final concentration) to 413 µM holo-ArCP and 
monitoring the loading reaction by HN-HSQC. After completion of the loading reaction, 
the sample was diluted 15-fold in identical buffer to lower the concentration of adenosine 
monophosphate (AMP) and pyrophosphate (PPi) produced by the loading reaction and 
additional YbtE added to increase the final concentration to 250 nM. This was concentrated 
to a final ArCP concentration of 360 µM. This sample was used to complete resonance 
assignments and collect dihedral angle constraints. The following experiments were 
performed on a sample in 90% H2O/10% D2O: HNCO (16 scans, 2048 (
1H, 16.019 ppm at 
4.698 ppm) × 64 (15N, 26 ppm at 117 ppm) × 75 (13C, 11 ppm at 174 ppm) complex points, 
10 hrs 20 mins), HNCA (16 scans, 2048 (1H, 16.019 ppm at 4.698 ppm) × 64 (15N, 26 ppm 
at 117 ppm) × 100 (13C, 30 ppm at 52 ppm) complex points, 13 hrs 44 mins), HNCACB 
(32 scans, 2048 (1H, 16.109 ppm at 4.698 ppm) × 64 (15N, 26 ppm at 117 ppm) × 150 (13C, 
60 ppm at 42 ppm) complex points, 1 day 18 hrs 14 mins), HNCACO (32 scans, 2048 (1H, 
16.019 ppm at 4.698 ppm) × 64 (15N, 26 ppm at 117 ppm) × 75 (13C, 11 ppm at 75 ppm) 
complex points, 20 hrs 55 mins). Following the HNCACO, the sample was buffer 
exchanged 150-fold into identical buffer as before to remove AMP and PPi and 
concentrated to 400 µM and the following experiment performed: HcccoNH (16 scans, 
2048 (1H, 16.019 ppm at 4.698 ppm) × 28 (15N, 26 ppm at 117 ppm) × 60 (1H, 7ppm at 
4.698 ppm) complex points, 1 day 14 hrs 7 mins). 
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A sample in D2O was used for aromatic side-chain resonance assignment and to collect 
distance constraints involving aliphatic and aromatic protons. Loading was performed with 
50 µM holo-ArCP, 50 nM YbtE, 2 mM ATP, and 500 µM 13C-salicylate in a total volume 
of 3.95 ml in 90% H2O/10% D2O and loading monitored by HN-HSQC. After loading was 
complete, the sample was buffer exchanged 560-fold into NMR buffer prepared in D2O 
containing 2 mM ATP and 500 µM 13C-salicylate and concentrated to a final loaded-ArCP 
concentration of 360 µM and the following experiments run: 2D-hbCBcgcdHD (800 scans, 
2048 (1H, 16.1092 ppm at 4.696 ppm) × 52 (13C, 22.0002 ppm at 30 ppm) complex points, 
13 hrs 39 mins) and 3D-NOESY-HC-HSQC (16 scans, 2048 (1H, 16.1092 ppm at 4.696 
ppm) × 100 (1H, 13 ppm at 4.696 ppm) × 50 (13C, 50.0003 at 69.5 ppm) complex points, 
mixing time of 90 ms, 4 days 15 hrs 54 mins).  
 
Relaxation Experiments  
15N-Holo-ArCP was generated by coexpression with Sfp such that the phosphopantetheine 
cofactor is also labeled. T1 and {HN}-heteronuclear-NOESY experiments were run on 300 
μM (T1 and het-NOE) and 380 μM (T2) holo samples with the following parameters: T1: 
24 scans, 2048 (1H, 16.1092 ppm at 4.700 ppm) × 128 (15N, 26 ppm at 117 ppm) complex 
points, 3s recycling delay, and relaxation delays of 0, 0.510, 1.02, and 1.53 seconds, 
collected in that order; T2: 16 scans, 2048 (1H 16.0192 ppm at 4.696 ppm) × 128 (15N, 26 
ppm at 117 ppm) complex points, 4s recycling delay, and relaxa-tion delays of 0.0, 0.140, 
0.350, 0.210, 0.070, and 0.280 seconds collected in that order; {HN}-heteronuclear-
NOESY: 100 scans, 2048 (1H, 16.0192 ppm at 4.700 ppm) × 78 (15N, 26 ppm at 117 ppm) 
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complex points, 5s recycling delay for reference experiment and 2s recycling delay 
followed by 3s saturation by 120° 1H pulses every 5 ms for saturation experiment. 
Salicylate-loaded ArCP was generated by incubating 50 µM 15N-holo-ArCP with 2 mM 
unlabeled salicylic acid, 2 mM ATP, and either 100 nM (R1, {HN}-Heteronuclear-
NOESY) YbtE in 3.5 ml total volume or 20 nM (R2 measurement) YbtE in 3.75 ml total 
volume and monitoring loading by HN-HSQC. Upon completion of loading, the sample 
was concentrated to 1 ml, diluted 15-fold in NMR buffer with 2 mM unlabeled salicylic 
acid and 2 mM ATP, and concentrated to a final protein concentration of 300 µM (R1, 
{HN}-Heteronuclear NOESY) or 390 µM (R2).  T1, T2, and {HN}-heteronuclear-NOESY 
experiments were run with the following parameters: T1: 24 scans, 2048 (1H, 16.1092 ppm 
at 4.697 ppm) × 128 (15N, 26 ppm at 117 ppm) complex points, 3s recycling delay, and re-
laxation delays of 0, 1.53, 0.510, and 1.02 seconds, collected in that order; T2: 16 scans, 
2048 (1H 16.0192 ppm at 4.696 ppm) × 128 (15N, 26 ppm at 117 ppm) complex points, 4s 
recycling delay, and relaxation delays of 0.140, 0.350, 0.210, 0.070, 0.280 and 0.0 seconds 
collected in that order; {HN}-heteronuclear-NOESY: 100 scans, 2048 (1H, 16.0192 ppm 
at 4.696 ppm) × 110 (15N, 26 ppm at 117 ppm) complex points, 5s recycling delay for 
reference experiment and 2s recycling delay followed by 3s saturation by 120° 1H pulses 
every 5 ms for saturation experiment with saturation and reference experiments collected 
in an interleaved manner. 
 
Relaxation parameters were fit using the program nlinLS, part of the NMRPipe software 
package95. In all experiments, line shapes in the 1H dimension were fit using a Gaussian 
function and line shapes in the 15N dimension were fit using a Fourier-transformed, 
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apodized, exponentially decaying sinusoid. Residues 20, 29, 34, 40, 88 and 91 were 
excluded from fitting in holo-ArCP due to severe overlap. In loaded-ArCP, residues 20, 
29, 32, 34, 75, 88, and 91 were excluded for the same reason. 
 
Lipari-Szabo model-free analysis was performed with the program ROTDIF72,73. ROTDIF 
fits both the overall rotational diffusion tensor as well as the model-free parameters at each 
residue, including Rex. Here, a first pass was performed to identify residues with order 
parameters of 0.75 or below. These residues were then excluded from analysis when fitting 
the global rotational diffusion tensor but were included when fitting the model-free 
parameters. In holo-ArCP the excluded residues were 14, 15, 51, 69, 90, and 93. In loaded-
ArCP residues 14, 15, 51, 69 and 93 were excluded. 
 
The “sausage” representations of Figure 13 were created using the PyMol97 “putty” feature 
after replacing each residue’s b-factor with its corresponding value of 1-S2.  
 
Structure Calculation  
Assignment of NOESY cross-peaks was performed manually using CARA96. 1636 
unambiguous restraints were assigned for holo-ArCP and 1314 for loaded-ArCP. In 
addition, 131 and 142 angle constraints were obtained with TALOS-N98. Structure 
calculations were performed using CYANA version 2.199. For the final structure 
calculation, 100 structures were calculated using 50,000 steps. The final CYANA target 
functions were 2.65 (for holo) and 2.99 (for loaded). There were no distance violations 
bigger than 0.5 Å and no angle violations larger than 3.5° in either NMR ensemble. The 
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average rmsd to mean for these conformers were 0.37 Å (backbone) and 0.88 Å (heavy) 
for holo and 0.36 Å (backbone) and 0.85 Å (heavy) for loaded. Other rmsd’s are described 
in the reminder of the text. The 20 structures with the lowest target function were chosen 
for water refinement in explicit solvent using CNS. Modified parameter and topology files 
were generated using the ACPYPE web application and refinement run using modified 
RECOORD scripts. The NMR ensembles were analyzed with the protein structure 
validation suite, PSVS, that includes PROCHECK_NMR100 and MolProbity101,102. 
Ramachandran statistics (PROCHECK) are: 93.6% in most favored region, 6.4% in 
additionally allowed, 0.0% in generously allowed, and 0.01% (G49 in loop1) in disallowed 
region for holo-ArCP and 92.4%, 7.6%, 0.0% and 0.0%, respectively, for loaded-ArCP. 
See also Tables 3-1 and 3-2. 
 
Surface potentials were generated using the APBS Tools2.1103 plugin for PyMOL using the 
default parameters. Input files were generated from pdb files of holo- and loaded-ArCP in 
which the phosphopantetheinylated serine was replaced with a standard serine using the 
pdb2pqr104,105 online server. 
 





Figure 3-2. Solution structures of holo (a,b) and loaded (c,d) ArCP. The lowest energy 
conformer of the NMR ensemble is shown for each form of the protein under two different 
views. e) detail of loop1 shown for holo (pink) and loaded (blue) ArCP. Structures were 
aligned with each other using helices α1 through α4. f) mean structures of Ser-PP from 
holo-ArCP (orange) and Ser-PP-Sal from loaded-ArCP (orange-red). The moieties were 




Table 3-1. NMR structure statistics from holo-ArCP. a, from CYANA 2.1. b, from 




Table 3-2. NMR structure statistics for loaded-ArCP. a, from CYANA 2.1. b, from 




Figure 3-3. NMR bundles for holo-ArCP (pink) and loaded-ArCP (blue). In holo-ArCP, 
alpha helices are colored as follows: α1: brown, α2: magenta, α3: pink, α4: beige. The 
corresponding colors for loaded-ArCP are α1: cyan, α2: sky blue, α3: royal blue, α4: 
green. Alignments made with Cα of residues in helices only. The NMR structure of the 
holo-ArCP core is defined by 1636 distance constraints and the protein core of loaded-
ArCP is defined by 1314 distance constraints. The residues masked by PP in holo-ArCP 
are S52, I53, M56, and L59 on α2 and L71, R72, and Y75 on loop 2 and α3. In loaded-





Figure 3-4. NOESY strips involving PP in holo-ArCP. The labels for PP moieties (Roman 
alphabet) are defined in Figure 3-1. Labls are positioned between two strips when the 
corresponding signals are observed in both. For corwded regions, the order of the labels 




Figure 3-5. NOESY strips of residues in holo-ArCP displaying NOESY cross-peaks with 
PP. Unlabeled cross-peaks denote cross-peaks within the protein core. A total of 50 
cross-peaks involving PP could be assigned unambiguously from peaks seen in Figures 3-
7 and 3-8. These include 14 nOe’s within the PP arm and 36 nOe’s between the protein 




Figure 3-6. NOESY strips involving PP in loaded-ArCP. The labels for PP moieties are 
defined in figure 3-1. For crowded regions, the order of labels from top to bottom refers to 




Figure 3-7. NOESY strips involving salicylate in loaded-ArCP. The labels for salicylate 
moieties are defined in figure 3-1. For crowded regions, the order of labels from top to 




Figure 3-8. NOESY strips of residues in loaded-ArCP displaying NOESY cross-peaks 
with PP. Unlabeled cross-peaks denote cross-peaks within the protein core. 8 nOe’s were 




Figure 3-9. NOESY strips of residues in loaded-ArCP displaying NOESY cross-peaks 
with salicylate. Unlabeled cross-peaks denote cross-peaks within the protein core. 12 
nOe’s were observed between loaded-ArCP and salicylate. The strip of Z2 (in salicylate) 
is shown to confirm the assignment of a NOESY cross-peak from Y75ε that overlaps 




Figure 3-10. Visualization of distance constraints involving prosthetic groups in holo-
ArCP (left) and loaded-ArCP (right). Lines in blue denote distance between the core 
protein and the prosthetic group, while lines in red denote distances within the prosthetic 
groups. Side chains of residues involved are show in black. Distance constraints are 




Figure 3-11. Change in conformation of prosthetic arm upon salicylate loading leads to 
different electrostatic surfaces in holo (left) and loaded (right) ArCP. Blue, positive 
charges; red, negative charges. Upon loaded, the change of the conformation in PP 
modifies access to both the positively charged and negatively charged surfaces. Surface 




Figure 3-12. Comparison of holo- (a, in pink) and loaded-ArCP (c, in blue) in complex 
with an adenylation domain in AT conformation (in white). The original structure of EntB-
ArCP (brown) in complex with EntE is shown in b) (2ROG). In b), EntB-ArCP sidechains 
2, those in blue show interactions between A(C) and ArCP, and those in green denote 
interactions between A(C) and loop1. The same color scheme was used for side-chains of 
EntE that are displayed in a-c). d) Detail showcasing changes in the conformation of loop1. 




Figure 3-13. NMR dynamics of holo and loaded-ArCP. (a-d) Residue-specific NMR 
relaxation parameters for holo (left, magenta) and loaded (right, cyan). The secondary 
structure of ArCP is illustrated below the plots (a) R1 relaxation rates (b) R2 relaxation 
rates (c) Heteronuclear NOE parameterized by Isat/Iref where  Isat and Iref are the amplitudes 





Figure 3-14. Dynamics visualization of holo (magenta) and loaded (cyan) ArCP, residues 
18-93. A thicker ribbon corresponds to a reduced order parameter and increased 
flexibility. Colors represent the Rex parameters fit during Lipari-Szabo analysis. Data are 
not available for residues in white due to overlap (e) holo-ArCP with the PP arm in its 
bound state (f) loaded-ArCP with the PP arm in its bound state (g) holo-ArCP with the PP 




Figure 3-15. Model-free analysis of holo (left) and loaded (right) ArCP. The analysis 
was performed using the software ROTDIF. ROTDIF selects which parameters to use 
when fitting based on the Akaike Information Criterion. For a given residue, parameters 
not selected have not been plotted. (A) Overall (S2) or slow time-scale (Ss
2, when Sf
2 is 
present) order parameters (B) Effective correlation time (C) Fast time scale order 
parameters (Sf




Figure 3-16. Chemical shift perturbations between major and minor forms in holo (top) 
and loaded (bottom) ArCP. The solid horizontal lines indicate the median (0.09 for holo, 
0.12 for loaded) and the median plus one standard deviation (std = 0.06 for holo, std = 0.07 
for loaded), respectively. The reported chemical shift differences are calculated with 
Δδ(1H, 15N)=(( ΔδH)2+(1/5(ΔδN)2)1/2, where ΔδI is the chemical shift difference between 
the two species for nucleus i. 
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Chapter 4-The solution structure of apo-ArCP reveals pre-formed binding sites for 
the phosphopantetheine arm and tethered substrate 
ABSTRACT: Carrier proteins (CPs) play a central role in nonribosomal peptide (NRP) 
synthesis. CPs are first modified from an inactive (apo) to active (holo) state via attachment 
of a phosphopantetheine (PP) arm. Substrate monomers are then directly attached to the 
PP arm via formation of a thioester to generate the loaded form. CPs interact with many 
different catalytic domains during synthesis and understanding how each of these 
modifications influences the structure of a CP will provide insight into the mechanism of 
NRP synthesis. In Chapter 3, I described the structures of holo- and substrate-loaded ArCP. 
Here, I describe the structure of apo-ArCP and thereby provide a structural view of ArCP 
as it exists in all of its possible forms. Comparison with the holo structure shows how 
attachment of the PP arm alters the conformation of helix 3 and examination of solvent-
exposed hydrophobic and aromatic residues shows that binding sites for both the PP arm 
and loaded salicylate are pre-formed in the apo structure. 
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In Chapter 2, I described the development of a novel method that enabled our lab to study 
the salicylate-loaded form of ArCP using NMR and in Chapter 3 I described the solution 
structures and dynamics of holo- and loaded-ArCP. The combined results from those 
studies offered us novel insight into how substrate loading influences the structure and 
dynamics of the CP to which it is tethered and allowed us to propose a means by which 
rearrangements of the PP moiety influence interactions with an adenylation domain. 
However, for a complete description of the influence of post-translational modifications on 
the structure of ArCP and their potential influence on modulating interactions with catalytic 
domains, the solution structure of ArCP in its unmodified (apo) form is needed. 
Comparison of the apo and holo forms will allow us to dissect the role of the PP arm in 
influencing the structure of ArCP and, in turn, how this influences interactions with 
catalytic domains. 
In this chapter, I describe the solution structure of ArCP in its apo form. Comparing the 
structure of apo-ArCP with holo-ArCP shows how hydrophobic interactions between the 
geminal methyl groups of the PP arm and aliphatic residues on ArCP lead to structural 
rearrangements that reposition regions of ArCP known to interact with catalytic domains. 
An examination of solvent-exposed hydrophobic residues shows that the binding sites for 
both the PP arm and tethered salicylate are pre-formed in the apo form and that this seems 
to be a general feature in carrier proteins. Finally, I compare the position of loop 1 between 
the apo, holo, and loaded forms and discuss the implications for modulating interactions 
with YbtE and PPTases. 
 
Results and Discussion 
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The solution structure for apo-ArCP was solved using CYANA 2.199 with 1128 distance 
constraints (14.1 per residue) obtained from a HN-NOESY-HSQC in H2O and a HC-
HSQC-NOESY in D2O along with 141 dihedral angle constraints from TALOS+
27 based 
on backbone chemical shifts. The 20 structures with the lowest target function were taken 
out of 100 calculated structures. This bundle had an average target function of 1.98 ± 0.13 
Å with no distance constraint violations greater than 0.5 Å and no dihedral angle constraint 
violations greater than 5°. The structural bundle has a backbone RMSD of 0.38 ± 0.10 Å 
and a heavy atom RMSD of 0.94 ± 0.10 Å, demonstrating that the structures calculated are 
both consistent with the constraints used to generate them and well-defined. 
The structures of apo-ArCP show the well-known four-helix bundle typical of carrier 
proteins107 (Figure 4-1). The bundle shows three longer helices, helix 1 (A18-L32), helix 2 
(S52-L65), and helix 4 (L80-L88) that are mostly parallel to one another and run in an up-
down-down fashion with a fourth, shorter helix, helix 3 (L71-L76), lying at a large angle 
to the others (Figure 4-2). S52, at the N-terminus of helix 2, is the 
phosphopantetheinylation site. Helices 1 and 2 are connected by a long loop (loop 1) while 
the other helices are connected by shorter loops (2 and 3). Finally, within loop 1 lies an 
additional single-turn helix, αI, which is also found in the holo and salicylate-loaded 
structures6. 
Comparison of the apo structure with that of holo- and loaded-ArCP shows that the overall 
structure is conserved between all three forms (Figure 4-3) and that the post-translational 
modifications only change the conformation of loop 1 and cause subtle rearrangement of 
the helices with respect to one another. The most notable of these is the repositioning of 
helix 3 with respect to helix 2 in the holo form. Phosphopantetheinylation of apo-ArCP 
  88 
causes helix 3 to move slightly towards the core of ArCP, as can be seen in Figure 4-4A. 
This is most likely driven by hydrophobic interactions between the geminal methyl groups 
at the base of the PP arm and aliphatic or aromatic residues found on helix 3, specifically 
L71 and Y75. Indeed, the methyl groups of the PP arm show nOe’s to the methyl groups 
of L71 and the α, β, and ring protons of Y75. Upon loading, salicylate docks on the surface 
of ArCP in between helices 2 and 3, increasing the space between the helices and returning 
helix 3 close to its position in the apo form (Figure 4-4B). In the loaded form the methyl 
groups of L71 seem poised to interact with the methyls of M56 and L59, but not with the 
geminal methyls of the PP arm. In both the holo and loaded forms of ArCP, the loop 
connecting helices 2 and 3 was found to be flexible. This flexibility allows the repositioning 
of helices 2 and 3 relative to each other as ArCP is converted among its various forms. This 
subtle repositioning likely contributes to the modulation of interactions with the A domain 
YbtE as helices 2 and 3 likely form the interaction surface for YbtE (Chapter 5). 
Another notable difference between the structure of apo-ArCP and those of holo- and 
loaded-ArCP is the length of helix 1 (Figure 4-3). In apo-ArCP, helix 1 begins at residue 
A18 (as recognized by PyMOL), while in the other forms this helix begins at R16. The 
results of the dynamics measurements shown in Chapter 3 indicate that residues near the 
end of helix 1 (A18-D20) are dynamic on a timescale slower than molecular tumbling (µs-
ms) and we proposed that this may be due to transient unfolding at the N-terminus of this 
helix6. In apo-ArCP, fewer interresidue nOe’s were observed for residues H17 and A18 
than in holo- and loaded-ArCP, consistent with this region being dynamic and largely 
disordered. 
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As in holo- and loaded-ArCP, the four-helix bundle is held together by hydrophobic 
interactions contributed by the large aromatic (F, W, and Y) and aliphatic (I, L, M, and V) 
residues of the four amphipathic helices (Figure 4-5A). Further, hydrophobic interactions 
between L34, L39, L45, and L50 on loop 1 and residues within the core of the protein 
anchor loop 1 to the surface and define its position relative to the four helices. Figure 4-5B 
shows that apo-ArCP has a predominantly hydrophilic surface surrounding a tightly 
packed, hydrophobic core. 
Closer inspection of the apo structure, however, shows that not all aliphatic or aromatic 
residues in apo ArCP are buried within the core. Figure 4-6 shows that residues I46 from 
loop 1 (on αI), I53, M56, and L59 from helix 2, and L71 and Y75 from helix 3 are all 
surface exposed in the calculated structures. Indeed, while the methyl or aromatic moieties 
of these residues all show strong nOe’s to other residues within this group, they show few 
or no nOe’s to other aliphatic residues, even immediate neighbors. For example, the methyl 
groups of I46 show strong nOe’s to Y75 but only one very weak nOe to the adjacent and 
solvent protected L45. These seven residues form an isolated and self-consistent 
hydrophobic patch on the surface of ArCP. 
Examination of the literature and comparison of the apo structure with that of holo- and 
loaded-ArCP suggest a role for each of the residues in this cluster. I53 (i+1 with respect to 
the PP site, S52) and M56 (i+4) are known to be important for interaction with 
phosphopantetheinyl transferases (PPTase), based on a co-crystal structure of a carrier 
protein and Sfp68. M56, L59 (i+7), and L71 (i+19) are all found to be covered by the PP 
arm in the structure of holo-ArCP (Figure 4-7A)6. The position at i+4 is thus important for 
mediating interactions with the PPTase and the PP arm. Finally, I46 (i-6) and Y75 (i+23) 
  90 
both have a direct interaction with the tethered salicylate in the structure of loaded-ArCP 
(Figure 4-7B)6. This demonstrates that the binding sites for the PPTase, PP arm itself, and 
tethered substrate are all pre-formed in the apo structure. This is in contrast to earlier reports 
that a binding site for the tethered substrate was not apparent in the first apo peptidyl carrier 
protein structure solved2; however, the authors of that study did not have a structure of a 
loaded NRPS CP at their disposal and may have been looking for a deep binding pocket 
instead of a shallow surface. 
The observation that solvent-exposed hydrophobic residues contribute to ArCP’s function 
suggests that they may play a key role in the function of all CPs. Indeed, residues at these 
positions are found to interact with the PP arm or tethered substrate in other holo- and 
loaded-CP structures108. Examining the structure of other apo NRPS CPs (those of EntB 
from enterobactin synthetase54, TycC3 from tyrocidine synthetase2,5, PCP7 from 
teicoplanin synthetase4, and PCP1 from yersiniabactin synthetase (Bradley Harden, 
personal communication)) shows that the position of these solvent-exposed residues 
corresponds to similar positions in ArCP or rationalizes alternative binding sites for the PP 
arm. This conserved feature suggests that the interaction between the PP arm and CP is 
driven at least in part by hydrophobic interactions between the methylene moieties of the 
PP arm and these hydrophobic and aromatic residues.  
In Figures 4-8 through 4-11 used in the discussion that follows, all residues not colored in 
cyan are solvent-exposed hydrophobic or aromatic residues. 
In all structures, the residue at i+1 is hydrophobic and is solvent-exposed. This is to be 
expected as this residue mediates the interaction with the PPTase68 and apo-CPs are 
inactive until they are phosphopantetheinylated. 
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EntB, which is also an aryl carrier protein, shows a similar pattern of solvent-exposed 
residues to ArCP54. The residues at positions i-6 (Ile), i+4 (Met), and i+19 (Phe) are all 
hydrophobic and solvent-exposed (Figure 4-8). Residues i+7 and i+8 are both alanines and 
may substitute together for the leucine found in ArCP at i+7 (Figure 4-8). Position i+23 is 
also occupied by an alanine (Figure 4-8). The substitution of the smaller alanine for a 
tyrosine may compensate for the extra hydroxyl group found in EntB’s tethered substrate, 
2,3-dihydroxybenzoate (DHB), compared with ArCP’s substrate, salicylic acid. Thus, 
binding sites for both the PP arm and DHB seem to be present in EntB as well. 
The apo and holo structures of TycC3 were originally solved in 2000 and at that time were 
proposed to be identical, based on very similar patterns of nOe’s found for the two forms2. 
However, it was also noted that small peaks were present in HN-HSQCs of both apo- and 
holo-TycC3, suggesting that both forms interconvert between a major and minor species. 
In 2006, solution structures of the major and minor states were solved5. This work 
suggested that the apo and holo forms share a common major state (A/H) but the apo form 
interconverts between the A/H state and an additional state (A) that is distinct from that of 
the holo (H). Notably, the position of the PP arm was proposed to change between the A/H 
and H state of holo-TycC3. In the A/H state, the PP arm interacted with residues near the 
beginning of loop 1, while in the H state it was found it interact with residues along helices 
2 and 3. In the original apo structure solved in 2000, aliphatic residues at i+4 (Met) and 
i+20 (Leu) are solvent-exposed, as in ArCP (Figure 4-9A). As in EntB, residues i+7 and 
i+8 are both alanines (Figure 4-9A). This shows that a pre-formed binding site for the PP 
arm is present in apo-TycC3, consistent with that found in ArCP. The residues at i-6 (Phe) 
and i+24 (also Phe) are also solvent-exposed aromatics, suggesting that a binding site for 
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the tethered substrate (tyrosine) is also present (Figure 4-9A). Further, the position at i-19, 
the residue proposed to interact with the PP arm in the A/H state, is a solvent-exposed 
valine (Figure 4-9B). This suggests that this valine may be part of an additional binding 
site. This additional hydrophobic patch is also seen in other CPs (discussed below) and 
suggests that multiple PP binding sites can be present on a single CP.  
The apo structure of PCP7Teic from the teicoplanin synthetase seems to show the same two 
PP binding sites as those proposed for TycC34,5. Similar to ArCP, i+4 (Met), i+7 (Ile), and 
i+20 (Ile) form a contiguous hydrophobic patch along helices 2 and 3 (Figure 4-10A). 
PCP7Teic also shows a hydrophobic patch spanning the C-terminus of helix 1 and the N-
terminus of helix 2 and comprised of residues at positions i+2 (Leu), i-18 (Leu), and i-19 
(Ile) (Figure 4-10B). The location of these residues is consistent with the second PP binding 
site found in TycC3. The authors of this study also solved the structure of holo-PCP7Teic, 
but were unable to identify any nOe’s between the core of the protein and the PP arm. 
Additionally, experiments with a paramagnetically-labeled PP arm were also inconclusive. 
The authors claimed that relaxation increased solely as a function of distance away from 
the PP attachment site, as would be expected for a completely unconstrained PP arm. 
However, their data appears to show enhanced relaxation at the N-terminus of helix 3, near 
residue i+20, suggesting that the PP arm does bind in a manner close to that seen in ArCP. 
Further, it is possible that the lack of nOe’s and the seemingly inconclusive paramagnetic 
relaxation enhancement data could be explained by rapid interconversion between an 
unbound state and two bound states, in which the PP arm interacts specifically yet 
transiently with the two sites described above. 
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Reinspection of apo-ArCP shows that the residue at i-20 is also a solvent-exposed leucine, 
showing that this alternative binding site also seems to be present in ArCP. While we did 
not find any evidence of an interaction between this region of holo-ArCP and the PP arm 
in our NOESY data, some signals from the PP arm show peak doubling, indicating the PP 
arm can adopt multiple different conformations. It is possible that the PP arm is binding in 
this region, but the population is too low for the interaction to be observed. 
The position of solvent-exposed aliphatic and aromatic residues in apo-ArCP, TycC3, and 
PCP7Teic could be used to rationalize varying observations about the placement (or lack 
thereof) of the PP arm in the various existing structures. It may therefore be possible to 
predict binding sites for the PP arm based on these solvent-exposed hydrophobic patches. 
In the structure of apo-PCP1, for which a holo structure is not yet available, residues at i-7 
(Phe) and i+23 (Phe) are both solvent-exposed and may form a binding site for loaded 
cysteine (Figure 4-11A). As shown in the structure of loaded-ArCP (Chapter 3), the curled 
conformation that the PP arm adopts in the loaded form positions the tethered substrate 
near the PP phosphate and the conserved aspartic acid at i-1. These negative charges may 
interact with the positively charged amine of the loaded amino acid and this charge-charge 
interaction may be a conserved feature of CPs loaded with amino acids. The residue at 
position i+19 (Leu) seems poised to form a binding site for the PP arm; however, the 
residues at positions i+4 and i+7 are both threonine, and the PP binding site identified in 
ArCP is decidedly more hydrophilic in PCP1 due to these substitutions (Figure 4-11A). 
Instead, the residues at i+2 (Leu), i-18 (Leu), and i-19 (Leu) seem to form an alternative 
binding site for the PP arm (Figure 4-11B), one that is consistent with that found for the 
A/H state from TycC3 and the second potential site from PCP7Teic. The holo structure of 
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PCP1 has not been solved yet and it will be interesting to see how the actual structure 
compares with the prediction made here. 
In Chapter 3, when comparing the structures of holo- and loaded-ArCP, it was shown that 
the position of a region of loop 1, namely that containing residues H40-S43 and centered 
on E41, was both subject to structural fluctuations on a µs time-scale and changed position 
upon substrate loading. We attributed that change in position to a change in conformational 
equilibrium caused by substrate loading, wherein direct interactions between I46 of loop 1 
and the tethered salicylate stabilized one conformation of loop 1 and therefore altered the 
observed position of E41 relative to that in the holo form6. Figure 4-12 shows an overlay 
of the position of E41 in apo-, holo-, and loaded-ArCP and shows that loop 1 in holo-ArCP 
adopts a conformation in between that seen in apo- and loaded-ArCP. One means of 
rationalizing this observation is that the position of loop 1 in the three forms lies along a 
trajectory between two states, one of which (state A) most resembles the apo from and the 
other of which (state B) most resembles the loaded form. The observed position of E41 in 
a given structure then reflects the relative populations in a conformational equilibrium. 
Comparison of the structures indeed shows a shift from state A towards state B as ArCP is 
modified from the apo form to the holo form and finally to the loaded form.  
Conclusion 
In this chapter, I presented the solution structures of apo-ArCP. Comparisons of apo-ArCP 
with holo- and loaded-ArCP show that covalent modifications cause only modest changes 
to the overall structure. These comparisons show that the binding sites for the PP arm in 
holo-ArCP and tethered salicylate in loaded-ArCP are already present in the apo structure. 
Comparison with structures of apo-CPs from other NRPS systems seems to show that pre-
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formed PP and tethered substrate binding sites seem to be a general feature of apo-CPs 
from NRPSs. In the following chapter, I will discuss how the structures of apo-, holo, and 
loaded-ArCP, together with binding studies, inform our understanding of protein-protein 

















Details about HNCA, HNCO, HNCACO, HNCOCA, and NOESY-HN-HSQC 
experiments can be found in the Methods section of Chapter 2. For assignment of aromatic 
residues, hbCBcgcdHD (288 scans, 2048 (1H, 16.019 ppm at 4.696 ppm) × 26 (13C, 22 ppm 
at 30 ppm) complex points, 4 hrs 55 mins ), hbCBcgcdceHE (672 scans, 2048 (1H, 16.019 
ppm at 4.696 ppm) × 26 (13C, 22 ppm at 30 ppm) complex points, ), and HC-HSQC-
NOESY (16 scans, 2048 (1H, 16.019 ppm at 4.696 ppm) × 100 (1H, 13 ppm at 4.696 ppm) 
× 50 (13C, 50.0003 ppm at 69.5 ppm) complex points, mixing time of 90 ms, 4 days 15 hrs 
54 mins) were run on a sample in 100% D2O.  
Structure Calculation 
Assignment of NOESY cross-peaks was performed manually using CARA. 1128 
unambiguous restraints were assigned for apo-ArCP. In addition, 141 angle constraints 
were obtained with TALOS-+. Structure calculations were performed using CYANA 
version 2.1. For the final structure calculation, 100 structures were calculated using 50,000 
steps. The final CYANA target functions was 1.98. There were no distance violations 
bigger than 0.5 Å and no angle violations larger than 5° in either NMR ensemble. The 
average rmsd to mean for these conformers were 0.38 (backbone) and 0.98 Å (heavy). The 
20 structures with the lowest target function were chosen for water refinement in explicit 
solvent using CNS and refinement run using RECOORD scripts. 




Figure 4-1. Cartoon representation of the structure of apo-ArCP. This structure shows the 
canonical four-helix bundle typical of carrier proteins, with three longer helices (α1, α2, 
and α4) running parallel to one another in an up, down, down configuration and a fourth, 
shorter helix (α3) lying at a large angle to the other three. A single-turn helix (αI) is found 
within loop 1 connecting helices 2 and 3. The conserved serine is shown in yellow sticks 




Figure 4-2. Cartoon representation highlighting the topology and relative orientation of 
the four major helices in apo-ArCP. α1, α2, and α4 are nearly parallel to each other while 




Figure 4-3. Comparison of the structures of apo-ArCP (green) with A) holo-ArCP 
(magenta, 2N6Y) and B) loaded-ArCP (blue, 2N6Z).  Overall, there are no major structural 
differences between apo-ArCP and either holo- or loaded-ArCP and most differences result 
in minor alterations in the relative positioning of the helices. The black arrow at the N-




Figure 4-4. Zoom in on the relative position of helix 3 when comparing apo-ArCP with A) 
holo-ArCP and B) loaded-ArCP. The asterisk denotes the position of the conserved serine 
at the N-terminus of helix 2. In holo-ArCP, phosphopantetheinylation causes helices 2 and 
3 to move towards each other relative to their positions in apo-ArCP. Salicylate loading 
causes the helices to return back to the position found in apo-ArCP in order to 
accommodate docking of the tethered salicylate.  
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Figure 4-5. A) Cartoon representations of apo-ArCP highlighting the amphipathic nature 
of the four major helices and loop 1. The large aromatic (F, W and Y) and large 
hydrophobic (I, L, M, V) residues are colored in red while all others are colored in cyan. 
B) Sphere and stick representation of apo-ArCP visualizing the hydrophobic core. The 
orientations are the same as those shown in A). The aromatic and hydrophobic residues 
form a tightly-packed core and the surface is decorated by hydrophilic amino acids, 




Figure 4-6. Cartoon (left) and sphere (right) representations of apo-ArCP highlighting 
the solvent-exposed hydrophobic residues that surround the conserved serine (denoted by 
an asterisk). Both views are shown in the same orientation. Coloring is the same as in 
Figure 4-5. Hydrophobic residues along α2, α3, and αI in the vicinity of the PP 




Figure 4-7. A) and B) show the same view as Figure 4-6 with key residues highlighted by 
color. The PP attachment site is in yellow, solvent-exposed hydrophobic residues that 
interact with the PP arm are shown in magenta, and residues that interact with salicylate 
are shown in blue. The residue colored in red immediately adjacent to the conserved serine 
is residue i+1, which mediates the interaction with Sfp. C) Magenta residues from B) 
shown on the structure of holo-ArCP with the PP arm shown in yellow. These residues 
form the binding surface for the PP arm. D) Blue residues from B) shown on the structure 
of loaded-ArCP with salicylate (PP arm not shown for clarity) in orange. The interaction 
surfaces for the PP arm and salicylate are clearly pre-formed in apo-ArCP. 
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Figure 4-8. Structure of apo-EntB-ArCP shown in the same orientation as apo-ArCP in 
Figure 4-7. Hydrophilic residues are colored in cyan and all other colors except yellow 
denote hydrophobic residues. The conserved serine is colored in yellow, putative PP 
binding surface (i+4, i+7, i+8, and i+19) in magenta, and putative DHB binding surface (i-
6 and i+23) colored in blue. EntB-ArCP appears to show similar pre-formed PP and DHB 




Figure 4-9. Cartoon and sphere representations of apo-TycC3 in A) the same orientation 
as apo-ArCP in Figure 4-7 and B) an alternative view center on α2 and focusing on the 
C-terminus of α1. Coloring is as in Figure 4-8. A) Residues i+4, i+7, i+8, and i+20, 
shown in magenta, form the PP binding surface proposed for the H state of holo-TycC3 
and consistent with that found for holo-ArCP. Residues i-6 and i+24, shown in blue, are 
solvent-exposed phenylalanines and form a potential interaction surface for a tethered 
substrate. B) A surface-exposed valine at the C-terminus of helix 1 is proposed to form an 




Figure 4-10.  Cartoon and sphere representations of PCP7Teic shown with the same color 
scheme and in the same orientations as in Figure 4-9. A) View highlighting residues (i+4, 
i+7, and i+20, magenta) that form a putative PP binding surface similar to that found in 
apo-ArCP. i-6 (Phe) and i+24 (Phe) shown in blue are solvent-exposed aromatic residues 
that form a potential binding surface for the tethered substrate. B) Alternative view of 
PCP7Teic shows an additional solvent-exposed hydrophobic surface comprised of residues 
i+2, i-18, and i-19 that form a putative PP interaction surface consistent with that proposed 
for the A/H state of holo-TycC3.  
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Figure 4-11. Cartoon and sphere representations of PCP1 shown with the same color 
scheme and in the same orientations as in Figure 4-9. A) apo-PCP1 seems to lack the same 
hydrophobic PP binding site as apo-ArCP, as residues 1+4 and i+7 are both threonines. 
Residues i-7 (Phe) and i+23 (Phe) form a potential binding site for tethered cysteine. B) 
Residues i+2, i-18, and i-19 (shown in magenta) form an alternative PP binding surface 




Figure 4-12. Zoom in on loop 1 of apo-, holo- and loaded-ArCP. Structures were aligned 
based on the four major helices. E41 is shown in sticks. The position of loop 1 in holo-
ArCP lies in between the positions observed for apo- and loaded-ArCP. 
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NMR structure statistics for apo-ArCP 
Violations (mean and s.d.)a  
 Distance constraints (Å) 0.38 +/- 0.03 
 Dihedral angle constraints (º) 2.52 +/- 0.56 
 Max. dihedral angle violation (º) 3.86 
 Max. distance constraint violation (Å)  0.46 
R. m. s. deviations geometry b  
 Bond lengths (Å) 0.016 
 Bond angles (º) 1.5 
Average pairwise r.m.s.d. [residues 21–90] (Å) a  
 Heavy 0.94 +/- 0.10 
 Backbone 
Ramachandran Statistics c 
      Most favoured 
      Additionally allowed 
      Generously allowed 
      Disallowed 






Table 4-1: NMR structure statistics for apo-ArCP. a from CYANA 2.199, b From PSVS101, 
c from ProCheck102. 
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Chapter 5-Structural rearrangements induced by covalent modification to carrier 
proteins modulate interactions with catalytic domains 
 
ABSTRACT: Nonribosomal peptide (NRP) synthesis is a complex process involving the 
interplay between covalent protein modifications, conformational changes, catalysis, and 
protein-protein interactions (PPIs). Delineating the mechanisms involved in orchestrating 
these various processes will deepen our understanding of domain-domain communication 
in NRPSs and lay the groundwork for the rational reengineering of NRPSs by swapping 
domains handling different substrates to generate novel natural products. While many 
structural and biochemical studies of NRPSs have been performed, few have focused on 
the thermodynamic parameters governing interactions in these systems. Here, I present my 
work aimed at understanding how covalent modifications to ArCP influences its 
interactions with YbtE. Using fluorescence anisotropy, isothermal titration calorimetry, 
and NMR titrations, I show that covalent modifications modulate the strength and nature 
of these PPIs in a manner that provides a logical directionality that permits efficient NRP 
synthesis. This is the first study analyzing binding between a carrier protein in all of its 
forms and a catalytic domain. The results will provide a basis for guiding the reengineering 




The modular nature of nonribosomal peptide synthetases (NRPSs) makes them an 
attractive target for bioengineering efforts, as in principle modules could be rearranged to 
produce novel products. Done in a combinatorial manner, this strategy could provide a 
limitless number of new natural products that could be tested for use as antibiotics or anti-
cancer agents. However, efforts to utilize this strategy have been limited by poor yields 
and it has not yet emerged as a viable means of producing novel peptides.  
Rational redesign of these systems necessitates an understanding of the molecular 
mechanisms governing NRPS synthesis. A full description of NRPS synthesis will 
incorporate structural studies, focusing on proteins of a size ranging from individual 
domains up to multi-module proteins, with biochemical and biophysical studies describing 
the thermodynamics of these systems. The work described in the previous two chapters has 
outlined our contributions to elucidating the structural and dynamic changes to carrier 
proteins upon various post-translational modifications. This builds upon previous efforts 
investigating the structure and dynamics of individual adenylation domains9, condensation 
domains19,109, and CPs2,4–6,54,108, a CP/TE didomain14, A/CP complexes10,11, and a full module 
with an apo CP18. Recent efforts have further expanded our structural understanding of 
NRPS synthesis by providing additional snapshots of full modules as they progress through 
NRP synthesis12,13. 
While these efforts have contributed significantly towards developing a structural 
understanding of NRPS synthesis and provided a number of snapshots of possible states, 
few have focused on the energetics governing transitions between these states. The study 
of the apo-CP/TE didomain showed that a conformational exchange between bound (CP 
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interacting with TE) and unbound forms was modulated by an interaction with a 
phosphopantetheinyl transferase (PPTase)14. It was also found that the terminal thiol of the 
PP arm of a holo-CP/A di-domain was protected when the A domain was bound to an 
adenylate mimic, suggesting that substrate binding by A domains promotes binding of the 
holo-CP and burial of the PP arm in the active site110. In order to monitor how molecular 
events modulate domain affinities, and how exogenous domains may still communicate 
with non-cognate partners in artificial NRPSs, it is necessary to first characterize the 
interaction of each state of a CP (apo, holo, and substrate-loaded) with each of its potential 
native interaction partners.  
Here, I used a combination of fluorescence anisotropy (FA), isothermal titration 
calorimetry (ITC), and NMR titrations to characterize the interactions between the 
adenylation domain, YbtE, and the apo, holo, and salicylate-loaded forms of ArCP. I also 
investigated the interaction between holo and salicylate-loaded ArCP and Cy1 using ITC. 
At the onset of these studies, we hypothesized that the catalytic domains would interact 
most strongly with the form of ArCP that serves as a substrate for its chemical reaction 
(holo-ArCP for YbtE, loaded-ArCP for Cy1) and weakly for the form that is a product of 
the reaction (loaded-ArCP for YbtE, holo-ArCP for Cy1) or inactive (apo). Fluorescence 
anisotropy titrations, ITC experiments, and NMR titrations all confirmed our expectation 
that YbtE would preferentially bind to holo-ArCP over apo-ArCP. However, NMR 
titrations revealed that apo- and holo-ArCP interact with YbtE with the same set of residues 
and thus raises questions about how YbtE discriminates between the two forms. Further, 
FA and ITC experiments showed that YbtE has a similar affinity for both holo- and loaded-
ArCP, a result seemingly inconsistent with our initial hypothesis. An examination of the 
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thermodynamics provided by the ITC experiments along with the structural and dynamics 
studies presented in the previous chapters leads me to propose a model whereby subtle 
structural rearrangements of the ArCP core and modulation of binding interfaces by the PP 
arm leads to differential binding modes that provide a logical directionality to this set of 
PPIs and permit efficient synthesis. 
Results 
In order to characterize the relative affinities of each of the forms of ArCP for the A domain 
YbtE, we first used fluorescence anisotropy (FA) due to the capacity to perform multiple 
titrations in parallel in a 384-well plate. Further, wild type ArCP does not feature any 
cysteine, which facilitates their engineering for controlled incorporation of fluorescent 
probes. Using site-directed mutagenesis, a single cysteine was engineered at position 16 of 
ArCP, at the very N-terminal end of helix 1. This site was chosen because helix 1 has never 
been found to be involved in interactions with catalytic domains and this residue is 
relatively rigid on a ps-ns timescale based on its high order parameter (see Chapter 3). 
Thus, a fluorescent probe at this position will not interfere with binding events and will be 
a good reporter of molecular tumbling. Apo-ArCP_R16C was labeled with fluorescein 
maleimide and divided into three aliquots, one of which remained apo, one of which was 
converted to the holo form, and the last of which was modified with a nonhydrolyzable 
amide analog of salicylcate-loaded phosphopantetheine (referred to as SalNH-ArCP). The 
latter allowed for monitoring binding of YbtE with its product, and thus for comparing the 
affinity between YbtE and its substrate and product. 
The results of the fluorescence anisotropy titrations are shown in Figure 5-1. As expected, 
YbtE shows a relatively weak interaction with apo-ArCP compared with holo-ArCP, with 
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apparent KD’s of 68.6 ± 9.62 µM and 7.22 ± 1.34 µM, respectively, based on fitting to a 
one-site specific binding model. This was expected because the apo form is inactive and 
therefore not a substrate for YbtE. However, we also found that YbtE binds to holo-ArCP 
and SalNH-ArCP with very similar affinities (KD’s of 7.22 ± 1.34 vs. 4.70 ± 1.10 µM). We 
had anticipated the interaction with SalNH-ArCP, a product of the chemical reaction 
performed by YbtE, to be comparatively weak; however, our FA titrations show this not to 
be the case. 
In order to both verify the results of the FA titrations and gain insight into the 
thermodynamics of each interaction, we performed ITC experiments with each form. All 
thermodynamic parameters are listed in Table 5-1. In these experiments, either apo-, holo-, 
or SalNH-ArCP was in the cell and YbtE in the syringe. The baseline-corrected data for 
each titration is shown in the top panel of Figures 5-2, 3 and 4 and the integrated signals 
fit to a 1:1 model are shown in the lower panels of the same figures. Prior to fitting, the 
integrated heat from the final four points of each titration was averaged and subtracted from 
all points to account for the heat of dilution. 
The results of the ITC experiments recapitulate the trends observed in the FA experiments. 
That is, YbtE binds relatively weakly to apo-ArCP (11.6 ± 1.89 µM) and interacts with 
holo- and SalNH-ArCP with similar affinities (2.70 ± 0.37 µM and 1.86 ± 0.18 µM, 
respectively). For holo- and SalNH-ArCP, the KD’s determined from the ITC experiments 
are also in good agreement with those found by FA. For apo-ArCP, neither FA nor ITC 
results fit well to a 1:1 binding model and the results will only be used qualitatively.  
The entropic and enthalpic contributions to each of these interactions are starkly different. 
The interaction between apo-ArCP and YbtE is endothermic, with a measured ΔH of 
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+0.610 ± 0.035 kcal/mol. This indicates that fewer favorable interactions are present in the 
complex than in the isolated proteins and their association is driven purely by a positive 
change in entropy, calculated to be 7.38 ± 1.10 kcal/mol. An interpretation of the 
thermodynamics of these interactions will be given in the discussion section below. In 
contrast to the interaction between apo-ArCP and YbtE, binding of YbtE to holo-ArCP is 
highly exothermic. A positive change in entropy also contributes to this interaction, 
although to a lesser extent than with apo-ArCP. Finally, a negative change in enthalpy and 
positive change in entropy both contribute to the interaction between SalNH-ArCP and 
YbtE. In this case, the contribution of enthalpy to the free energy of binding is lower than 
that seen for holo-ArCP (1.421 ± 0.021 kcal/mol vs. 3.501 ± 0.084 kcal/mol) and the 
interaction with SalNH-ArCP has a more favorable change in entropy. This suggests that 
even though holo-ArCP and SalNH-ArCP have similar affinities for YbtE, they interact 
with YbtE via rather different mechanisms. 
Finally, to identify the residues on ArCP that mediate the interaction with YbtE, we 
performed NMR titrations with the apo and holo forms. In these experiments, 15N-labeled 
ArCP was held at constant concentration and unlabeled YbtE was titrated. An HN-HSQC 
was collected at each concentration of YbtE. SalNH-ArCP was not available when the 
titrations were performed. 
Figures 5-5 and 5-6 show the spectroscopic signature of complex formation for apo- and 
holo-ArCP, respectively. First, it can be seen that all signals are not affected in a uniform 
manner, demonstrating that binding is specific to a subset of residues. Additionally, 
comparison of signal line-shapes and positions during apo- and holo-ArCP titrations 
confirms that YbtE preferentially binds to holo-ArCP over apo-ArCP. The signals in the 
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apo-ArCP titration show large changes in chemical shift but small changes in intensity 
upon interaction, indicative of fast exchange on the NMR time-scale. In contrast, at 
equivalent concentrations of YbtE, signals of holo-ArCP broaden and disappear into the 
noise without a significant change in position at equivalent concentrations of YbtE, 
characteristic of intermediate exchange and demonstrating a tighter interaction than that 
with apo-ArCP. 
In Figures 5-7 and 5-8, residues affected by the interaction are plotted onto the structures 
of apo- and holo-ArCP. For apo-ArCP, the signals are colored according to the 
concentration of YbtE at which they passed a threshold chemical shift perturbation while 
for holo-ArCP they are colored based on the concentration at which the signal became 
undetectable. Surprisingly, the patterns shown for apo- and holo-ArCP are remarkably 
similar. For both forms, all residues affected cluster along the solvent-exposed faces of 
helices 2 and 3. Figures 5-7 and 5-8 show that these residues form a continuous patch along 
the surface of ArCP that is nearly identical between the two forms. This demonstrates that 
YbtE interacts with apo- and holo-ArCP at the same surface despite having different 
affinities for the two forms and significantly different thermodynamics for the two 
interactions.  
ITC experiments were also performed to attempt to characterize the interaction between 
Cy1 and holo- or SalNH-ArCP and the results are shown in Figure 5-9. Even with 100 µM 
holo- or SalNH-ArCP in the cell, no interaction could be detected. One possible 
explanation for this result is that Cy1 needs to first bind to the downstream CP, PCP1, 
before it can bind ArCP. It is also possible that the Cy1 construct we are using is simply 
inactive and new constructs need to be tested. 
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Discussion 
Prior to our investigations, little was known about whether or how NRPS catalytic domains 
discriminate between the various forms in which CPs exist. Before structures of multi-
domains became available, there were two competing models of NRPS synthesis. In the 
first model, NRPS were expected to display a rigid organization with the long, flexible PP 
arm swinging between catalytic sites. In the second model, NRPSs acted as bead on a string 
and domains would randomly interact with each other during synthesis. Crystallography, 
NMR, and CryoEM have since shown that the reality lies somewhere in between both 
models: NRPSs seem to adopt a series of transient, well-defined quaternary conformations 
during synthesis. However, it is still unclear how NRPSs stabilize the relevant 
conformation in each catalytic step. One possibility is that catalytic domains do not 
discriminate between the carrier protein forms, but instead the CPs randomly visit the 
various active sites available and chemistry occurs when the relevant pair of CP and 
catalytic domain is formed. Alternatively, chemical modifications of CPs may modulate 
interactions between CPs and catalytic domains. Here, I show how covalent modifications 
modulate both the affinity and the nature of domain-domain interactions. 
We originally hypothesized that the strength of the interactions between ArCP and the 
catalytic domains would reflect ArCP’s role as either a substrate or product of the various 
chemical reactions. That is, holo-ArCP should interact strongly with YbtE but weakly with 
Cy1, SalNH-ArCP should interact strongly with Cy1 but weakly with YbtE, and apo-ArCP 
should interact weakly with both since it is a substrate for the phosphopantetheinyl 
transferase YbtD but not YbtE or Cy1. While we found that YbtE preferentially interacts 
with the holo form over the apo form, we also found that it binds to holo- and SalNH-ArCP 
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with similar affinity. Further, despite our FA, ITC, and NMR titration results indicating a 
preference for holo-ArCP over the apo form, the NMR titrations showed that YbtE interacts 
with the two forms at very similar interfaces. Comparison of the measured dissociation 
constants and interaction surfaces alone does not provide a rationale for understanding how 
YbtE discriminates between these two forms, nor do the binding affinities rationalize the 
tight association between YbtE and SalNH-ArCP. Instead, a consideration of the entropic 
and enthalpic contributions to each interaction along with the structures presented in the 
previous two chapters is necessary to understand how the biochemical state of ArCP 
modulates the affinity for YbtE in a manner that reflects its role as a substrate or product 
of the loading reaction. 
As shown in Figure 5-10 and listed in Table 5-1, although the apparent KD’s for the three 
forms are all within an order of magnitude and are effectively identical for the holo and 
loaded forms, the relative contribution of enthalpy and entropy to each interaction varies 
widely. For apo-ArCP, the interaction is enthalpically unfavorable and is therefore driven 
exclusively by a favorable change in entropy. For holo-ArCP, changes in entropy and 
enthalpy contribute almost equally to the interaction, while for SalNH-ArCP, the 
interaction is driven predominantly by a favorable change in entropy but is still exothermic. 
In order to interpret these thermodynamic parameters mechanistically, it is necessary to 
consider the individual factors that contribute to the overall changes of enthalpy and 
entropy upon interaction. Changes in enthalpy arise from making or breaking chemical 
interactions, such as van der Waal’s contacts, hydrogen bonds, and charge-charge 
interactions111. When more bonds are formed than broken, the change in enthalpy will be 
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negative and drive an interaction (as for holo- and SalNH-ArCP), while the opposite is true 
if more bonds are broken than formed (apo-ArCP). 
Changes in entropy come from a greater number and wider variety of sources and can be 
attributed to changes involving the solvent (ΔSsolv) or the interacting molecules themselves 
(ΔSmole)
111. ΔSmole can be broken down into changes in conformational entropy (ΔSconf), 
translational and rotational entropy, and residual entropy111. When considering complex 
formation, ΔSconf refers to the number of conformations (tertiary structures) each binding 
partner can adopt. The total change in entropy upon association is the sum of ΔSsolv and 
ΔSmole and will incorporate changes in entropy from both ArCP and YbtE. The following 
discussion will focus on ΔSsolv, which can be calculated
112,113, and ΔSconf, which will be 
discussed qualitatively. 
A positive ΔSsolv is generally considered to come from a release of ordered water molecules 
away from the surfaces of two interaction proteins and into bulk solution111. This reflects 
the burial of nonpolar groups at the protein-protein interface and can be calculated as a 
function of temperature based on the changes in solvent-accessible surface area (ΔASA) of 
polar and nonpolar groups as ΔSsolv(T)=0.45*ΔASAnonpolar*ln(T/385)-
0.26*ΔASApolar*ln(T/335) in units of cal*mol
-1*K-1.112,114 While there is no structure 
available of an ArCP:YbtE complex, there is a co-crystal structure of the homologs EntE 
and EntB from the enterobactin system with EntE in the thioester conformation10. This 
arrangement is expected to maximize the interaction surface between A domain and CP. 
Calculating ΔSsolv based on this crystal structure and T=300K (temperature at which ITC 
experiments were performed) gives a ΔSsolv of 17.1 kcal/mol. This value likely only holds 
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for apo- and holo-ArCP, which were shown by NMR titration to interact with YbtE at the 
same surface as that found in the EntE:EntB co-crystal structure and may be lower for 
SalNH-ArCP, which we propose has a smaller interaction surface. 
ΔSconf reflects the total number of conformations available to a protein in different states. 
When a discrete number of conformations can be identified, this can be calculated as 
ΔS=kBln(n2/n1), where ni represents the number of conformations available in state i
111. As 
can be seen, if fewer conformations are available in state 2 than state 1 (for example, bound 
vs. unbound), the contribution to the overall entropy will be negative and will disfavor 
binding. A domains are comprised of two sub-domains, a large N-terminal domain and a 
smaller C-terminal domain, and adopt a number of different conformations that differ in 
the relative orientation of the sub-domains9. The so-called adenylation conformation is 
proposed to catalyze formation of the acyl-adenylate. The C-terminal domain is then 
proposed to rotate 140° to form the thioester conformation, which interacts with holo-CPs 
to catalyze substrate loading. The number of states available to YbtE must therefore be 
considered. Additionally, the number of conformations available to ArCP varies depending 
on the form. Apo- and holo-CPs have been reported to exist in two states5, named A and 
A/H for the apo form and A/H and H for the holo form(see chapter 4), although the 
significance of this observation has recently been debated68. In addition to having multiple 
conformers of the core protein, holo-ArCP harbors a highly flexible PP arm that 
interconverts between a bound and unbound form. Further, in the unbound state the PP arm 
itself exists in a disordered state sampleing multiple conformations as evidenced by NMR 
relaxation parameters (Chapter 3). Apo-ArCP has no modifications and likely has fewer 
possible conformations than holo-ArCP. Finally, the salicylate-loaded PP arm is also 
  121 
dynamic and also likely adopts multiple conformations, although it is less flexible than the 
PP arm of holo-ArCP based on the NMR dynamics measurements presented in Chapter 3. 
All of these dynamic events must be taken into account when discussing binding. 
The interaction between apo-ArCP and YbtE is endothermic, indicating that fewer 
favorable interactions are present in the complex than in the free proteins, and complex 
formation is therefore driven entirely by favorable changes in entropy. As noted above, 
ΔSsolv contributes 17.1 kcal/mol, significantly higher than the 7.38 ± 1.10 kcal/mol 
calculated from the ITC data. I propose that selection of a single conformation of YbtE 
upon binding accounts for a portion of the difference between ΔSsolv and the measured 
entropy via a negative change in conformational entropy. This pre-existing conformational 
exchange by YbtE may also rationalize the endothermic nature of the interaction. As 
described in Chapter 1, A domains have crystallized in at least three different 
conformations and may access many more in solution. However, only one, the thioester 
conformation, is expected to interact with holo-ArCP and, due to the similarity in binding 
interfaces identified in the NMR titrations, probably the apo form as well. Comparison of 
the solvent-accessible surface area of the C-terminal domain in the adenylation (calculated 
for DhbE115, another homolog of YbtE and EntE) and thioester conformations (EntE10) 
shows that an additional 206.7 square angstroms is buried in the adenylation conformation, 
which must therefore feature more intradomain interactions. Hence, the transition from the 
adenylation to thiolation conformation may therefore require an input of energy, making it 
an endothermic process. The amount of energy necessary to make this transition is 
apparently greater than that provided by the interaction with apo-ArCP, making the overall 
process of the conformational change plus the interaction with apo-ArCP endothermic. 
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Additionally, selecting for the thioester conformation out of multiple possible 
conformations would also negatively contribute to the overall change in entropy, as n2 < 
n1, making ln(n2/n1) negative. Based on these considerations, release of water into bulk 
solution is likely the main driving force for the interaction between apo-ArCP and YbtE.  
In contrast to apo-ArCP, the interaction between holo-ArCP and YbtE is driven almost 
equally by entropy and enthalpy. The contribution of entropy to this interaction is less than 
for the interaction with apo-ArCP. As we showed in Chapter 3, the PP arm on holo-ArCP 
is highly dynamic and likely interconverts between a bound form and many unbound 
forms, only one of which is present upon an interaction with an A domain6 (referred to as 
e-holo-ArCP in Chapter 3). Therefore, the association of YbtE and holo-ArCP likely 
selects for a single conformation of YbtE and a single conformation (out of many) of holo-
ArCP, leading to a further reduction in ΔS. Notably, despite using the same interaction as 
apo-ArCP as indicated by NMR titrations, this interaction becomes strongly exothermic, 
not endothermic. The PP arm itself is only expected to interact weakly with the A domain, 
based on the crystal structure of the EntE:EntB complex10 and biochemical data showing 
that free phosphopantetheine is a poor substrate for A domains116, so this is unlikely to be 
the source of the additional favorable interactions. In Chapter 4, I described how 
phosphopantetheinylation causes a minor rearrangement of helices 2 and 3 due to a 
hydrophobic interaction between residues at the N-terminus of helix 3 and the methyl 
groups on the PP arm. According to our NMR titrations, helices 2 and 3 comprise the 
interaction surface for YbtE. Phosphopantetheinylation thus appears to properly position 
the residues in this region for an optimal interaction with an A domain, leading to stronger 
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interactions and a negative enthalpy that more than compensates for the entropy lost due 
to freezing out the motion of the PP arm. 
Finally, while loaded-ArCP binds to YbtE with similar affinity as holo-ArCP, the 
thermodynamics of the interaction are quite different and provide insight into the nature of 
the interaction (Figure 5.10). This interaction is exothermic, although less so than the 
interation between holo-ArCP and YbtE by ~2.1 kcal/mol. To achieve a similar overall 
binding affinity, this interaction is more entropically favorable than that of holo-ArCP. 
Again, the structures and dynamics described in Chapter 3 allow us to rationalize this 
observation. In the loaded form, ArCP interacts directly with the tethered substrate. This 
interaction positions the PP arm such that the PP arm and substrate obscure helices 2 and 
3, but not loop 1. In the co-crystal structure of EntE and EntB, loop 1 of EntB appears to 
interact with the C-terminal domain of EntE10. We proposed that the interaction with the 
substrate breaks the interaction with the N-terminal domain while maintaining an 
interaction with the C-terminal domain. We further proposed that this would free the C-
terminal domain to rotate relative to the N-terminal domain in order to deliver the CP to 
the condensation domain6, an idea supported by recent crystal structures12,13. Based on this 
model, the loaded-ArCP:YbtE interaction would have a smaller interface than that with 
holo-ArCP, forming fewer interactions and therefore having a smaller change in enthalpy, 
while also freeing the C-terminal domain to sample multiple conformations, increasing the 
number of states possible and therefore increasing the entropy of the bound form relative 
to the complex formed between YbtE and holo-ArCP. 
The sum of these results allows us to build a model of how covalent modifications provide 
directionality to the set of protein-protein interactions necessary for substrate loading. First, 
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phosphopantetheinylation of apo-ArCP repositions residues at a pre-formed binding site, 
optimizing the interactions and providing the additional energy that results in preferential 
binding of YbtE to holo-ArCP over apo-ArCP. Substrate loading then obscures part of this 
binding surface, partially disrupting the protein-protein interaction but freeing the C-
terminal domain to rotate. In the context of a full module, this would allow the A domain 
to deliver the loaded-CP to the next catalytic domain. The combination of NMR structural 
and dynamic studies with FA, ITC, and NMR titrations presented throughout this work 
thus allows us to propose a model in which covalent modifications to ArCP impart a 
directionality to the set of interactions with YbtE in a manner that parallels the chemical 
steps of elongation. 
The work described here serves as a starting point for analyzing the influence of additional 
substrates on the interaction between catalytic domains and carrier proteins. All of our 
titrations were done with free YbtE; however, for loading to occur, YbtE would contain an 
activated salicyl-adenylate in its active site. Our studies with free YbtE will serve as a point 
of reference for titrations done in the presence of salicylate, ATP, or the nonhydrolyzable 
saliycl-adenylate mimic Sal-AMS.  
Finally, the binding studies done here between a wild-type A domain and its cognate CP 
will also guide efforts to reengineer NRPS systems. Interactions between A domains and 
non-cognate CPs or mutant A domains with altered substrate specificity and their cognate 
CPs can be optimized to match the binding affinities and thermodynamics measured for 
ArCP and YbtE. The mechanistic insights into NRPS synthesis provided by our work 
combining NMR structural and dynamic data with FA, ITC, and NMR titrations thus lay 
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the foundation for engineering artificial NRPS systems and the production of novel 




Expression and Purification of PanK, Ppat, and DPCK 
Unless otherwise noted, pH listed for each buffer is the pH at 4 °C. 
Expression and purification of PanK, Ppat, and DPCK is identical except where noted. 
Plasmids encoding for PanK, Ppat, and DPCK (courtesy of Dr. Craig Townsend) were 
transformed into E. coli BL21 (DE3) cells and plated on luria broth (LB) agar with 
kanamycin. A single colony was selected and added to 15 ml LB with kanamycin and 
grown at 37 °C with shaking at 250 rpm overnight. The following day, 10 ml of the 
overnight culture was added to 1 L LB with kanamycin and growth continued at 37 °C with 
shaking. At OD600=0.6, cultures were placed in an ice bath and allowed to cool to 15 °C. 
IPTG was then added to a final concentration of 1 mM and growth continued at 16 °C with 
shaking for 16 hours. Cells were harvested by centrifugation and pellets flash frozen in 
liquid nitrogen. Pellets were stored at -80 °C until needed. 
To begin purification, cell pellets were resuspended in 50 ml lysis buffer (50 mM Tris, pH 
8.0, 0.5 M NaCl, 30 mM imidazole 200 µg/ml lysozyme, 2 µg/ml DNase I) and lysed using 
either a microfluidizer or French pressure cell. The lysate was clarified by centrifugation 
at 27,000 xg for 30 minutes at 4 °C. The supernatant was filtered and loaded onto a 5 ml 
HisTrap HP column. The column was washed with 16 column volumes (CV) His Buffer 
A (50 mM Tris, pH 8.0, 0.5 M NaCl, 30 mM imidazole) on an Aktapurifier while collecting 
fractions. The column was eluted with a linear gradient from 0-100% His Buffer B (50 mM 
Tris, pH 8.0, 0.5 M NaCl, 0.5 M imidazole) over 25 CV while collecting fractions. 
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Fractions were analyzed by SDS-PAGE and fractions containing desired protein were 
pooled and dialyzed against 2 L 20 mM Tris, pH 7.5, 0.1 M NaCl at 4 °C overnight. 
The following day, the samples were concentrated to 2 ml or less and loaded onto a 
Superdex 200 16/60 pg size exclusion column that had been equilibrated with 20 mM Tris, 
pH 7.5, 0.1 M NaCl and run at max flow-rate (1.2 ml/min) while collecting fractions. 
Fractions were analyzed by SDS-PAGE and fractions containing pure target protein 
pooled. 
Removal of Contaminating Coenzyme A from Ppat and PanK 
Ppat and PanK co-purify with coenzyme A, which will result in contamination of samples 
with holo-CP. ATP is a competitive inhibitor of Coenzyme A and was used to remove 
bound Coenzyme A from Ppat and PanK. To remove coenzyme A, Ppat and PanK were 
buffer exchanged into 20 mM Tris, pH 7.5, 0.1 M NaCl, 20 mM ATP by repeated 
concentration and dilution in this buffer until a 1000-fold exchange had been achieved. 
Samples were then exchanged into 20 mM Tris, pH 7.5, 0.1 M NaCl, 10% glycerol (v/v) 
by repeated concentration and dilution until a 1,000-fold exchange had been achieved.  
DPCK was also exchanged into 20 mM Tris, pH 7.5, 0.1 M NaCl, 10% glycerol (v/v) in 
the same manner. Samples were then concentrated, aliquoted, flash frozen in liquid 
nitrogen, and storted at -80 °C until needed. Concentrations were determined by UV-vis 
absorbance at 280 nm. Extinction coefficients used were 45380/M*cm (PanK), 
8480/M*cm (Ppat), and 16960/M*cm (DPCK). 
 
Modification of Apo-ArCP with Nonhydrolyzable Amide Mimic for ITC 
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A 10 ml reaction in 100 mM Tris, pH 7.5 at 22 °C, 10 mM MgCl2, and 100 mM NaCl with 
50 µM apo-ArCP, 150 µM nonhydrolyzable amide mimic, 5 mM ATP, 500 nM Sfp, 500 
nM PanK, 500 nM Ppat, and 500 nM DPCK was prepared and incubated at room 
temperature for 4 hours. The sample was then concentrated and run on a Superdex 75 16/60 
pg (GE Healthcare) size exclusion column that had been equilibrated with ITC buffer (50 
mM ACES, pH 6.80 at 22 °C, 150 mM NaCl, 1 mM MgCl2, 2 mM TCEP) and peak 
fractions collected. Fractions were analyzed by SDS-PAGE and completion of reaction 
confirmed using MALDI. 
ITC Experiments 
For all ITC experiments, ITC buffer (50 mM ACES, pH 6.80 at 22 °C, 150 mM NaCl, 1 
mM MgCl2, 2 mM TCEP) was used. 
ITC experiments were performed using a VP-ITC Microcalorimeter (MicroCal). 
YbtE was purified as described in Chapter 2. 
To prepare YbtE or Cy1 for titrations, samples were exchanged >100-fold into freshly 
prepared ITC buffer by repeated concentration and dilution in a 30K MWCO centrifugal 
filter (Millipore). Samples were then filtered through a 0.45 µm filter to remove any 
precipitate that had formed during concentration. A 5 µl sample was taken and diluted 5-
fold into ITC buffer. 5 µl of this was then diluted 20-fold into 6.3 M guanidinium-HCl. 5 
µl of ITC buffer was also diluted 20-fold into 6.3 M guanidinium-HCl to use as a blank. 
A280 was measured and the concentration calculated using extinction coefficients of 
52370/M*cm (YbtE) and 80000/M*cm (Cy1). Samples were then diluted to the final 
working concentration and stored on ice until needed. 
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Samples of ArCP were exchanged >100-fold into freshly prepared ITC buffer by repeated 
concentration and dilution in a 3K MWCO centrifugal filter. Samples were filtered through 
a 0.45 µm filter to remove any precipitate that had formed during concentration. A 5 µl 
sample was taken and diluted 20-fold into 6.3 M guanidinium-HCl. A blank was prepared 
as described above. A280 was measured and the concentration calculated using an extinction 
coefficient of 20970/M*cm. Samples were diluted to the final working concentration and 
stored on ice until needed. 
All samples were degassed prior to use. 
For experiments with YbtE, ArCP (40 µM) was in the cell and YbtE (720 µM) in the 
syringe and the following settings used: Cell temperature: 27 °C; Reference power: 20 
µcal/second; Initial delay: 600 seconds; Stirring speed: 300 rpm; Feedback mode: High; 
Equilibration options: Fast equil./Auto. The injection schedule was as follows: one 2 µl 
injection with 150 second delay followed by 24 12 µl injections with 300 second delays. 
Data was analyzed using Origin. 
For experiments with Cy1, ArCP (100 µM) was in the cell and Cy1 (1.2 mM) in the syringe 
and the following settings used: Cell temperature: 27 °C; Reference power: 4 µcal/second; 
Initial delay: 600 seconds; Stirring speed: 300 rpm; Feedback mode: High; Equilibration 
options: Fast equil./Auto. The injection schedule was as follows: one 2 µl injection with 
150 second delay followed by 20 15 µl injections with 300 second delays. For titration of 
Cy1 into buffer, the cell contained only ITC buffer but all settings were identical. For 
titrations of buffer into ArCP, the syring contained only ITC buffer but all settings were 
identical. Raw data was integrated in Origin and plotted using Prism 5. 
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Cloning of ArCP_R16C 




the Phusion High-Fidelity Master Mix with High Fidelity Buffer according to the protocol 
recommended by the manufacturer (New England Biolabs). The reaction contained 5% 
DMSO and used the following PCR protocol: 1 round of 30 seconds at 98 °C; 30 rounds 
of 10 seconds melting at 98 °C, 30 seconds annealing at 72 °C, 5 minutes extension at 72 
°C; 1 round of 10 minutes extension at 72 °C. Colonies containing the proper mutation 
were identified by sequencing.  
Expression and purification of ArCP_R16C are the same as for apo-ArCP 14-93 (Chapter 
2) except dialysis buffers contain 2 mM DTT and the final size exclusion buffer was FA 
Labeling Buffer (10 mM HEPES, pH 7.5, 150 mM NaCl, 500 µM TCEP). 
Fluorescent Labeling of apo-ArCP_R16C 
Purified apo-ArCP_R16C (5 mg) in FA Labeling Buffer was concentrated to a volume of 
~3 ml and Triton X-100 added to a final concentration of 1% (w/v). 1 mg of fluorescein-
5-maleimide (Vector Laboratories) dissolved in 30 µl DMSO was then added to apo-
ArCP_R16C. Tubes were wrapped in parafilm and aluminum foil and rocked at 4 °C 
overnight. 
The following day, β-mercaptoethanol was added to a final concentration of 10 mM and 
rocking continued at 4 °C for one hour. Excess dye was removed by repeated concentration 
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and dilution in FA Labeling Buffer and the sample concentrated to 2 ml. The sample was 
then run on a Superdex 75 16/60 pg that had been equilibrated with ITC buffer. Peak 
fractions were analyzed by SDS-PAGE and fractions containing ArCP were pooled. This 
pool was divided into three aliquots: one remained apo, one was phosphopantetheinylated 
as described in Chapter 2, and the other was modified with a nonhydrolyzable amide mimic 
as described above.  
Protein concentration and degree of labeling were calculated according to the 
manufacturer’s protocols. Degree of labeling was found to be 0.282 (apo-ArCP), 0.352 
(holo-ArCP), and 0.344 (SalNH-ArCP). Glycerol was added to 10% (w/v) and samples 
flash frozen in liquid nitrogen and stored at -80 °C until needed. After thawing and before 
use in titrations, samples were dialyzed against freshly prepared ITC buffer such that a 
>10,000-fold dilution of glycerol was achieved. 
To prepare samples for fluorescence anisotropy titrations, YbtE was buffer exchanged 
>100-fold into freshly prepared ITC buffer by repeated concentration and dilution. The 
sample was filtered and concentration determined by diluting 5 µl 20-fold in 6.3 M 
guanidinium-HCl and measuring the A280. A series of 2X YbtE samples was then created 
from this stock. A 2X stock of fluorescently labeled ArCP was made by diluting 
concentrated samples to 80 nM in ITC buffer. Final samples were made by mixing 30 µl 
2X YbtE with 30 µl 2X ArCP in 1.5 ml microcentrifuge tubes. The final concentration of 
ArCP was 40 nM. The final concentrations of YbtE were 0, 1, 2, 5, 10, 15, 20, 30, 40, 60, 
80, 100, 150, 200, and 300 µM for titrations with apo-ArCP and 0, 0.25, 0.5, 0.75, 1, 2, 4, 
6, 8, 10, 15, 20, 30, 40, 60, 80, and 100 µM for titrations with holo- and SalNH-ArCP. 
Samples were briefly spun in a table top centrifuge and incubated in the dark for 20 
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minutes. Samples were then further mixed by pipetting, 40 µl added to a 384-well plate 
(Corning #3575), and incubated in the dark for an additional 20 minutes before reading. 
Measurements were performed on a Tecan M1000 Infinite PRO plate reader. The G-factor 
was determined using 1 nM fluorescein in 0.01 M NaOH and the anisotropy readings 
averaged across five wells. The excitation wavelength was 470 nm with 5 nm bandwidth. 
The emission wavelength was 518 nm with 8 nm bandwidth. 200 flashes were used for 
each point. Background fluorescence was averaged across 5 wells containing only ITC 
buffer. Data was analyzed using Prism. 
NMR Titrations of Apo- and Holo-ArCP with YbtE 
15N-labeled apo-ArCP was purified as previously described (Chapter 2). 15N-labeled holo-
ArCP was generated as previously described (Chapter 2). YbtE was purified as previously 
described (Chapter 2). 
To prepare for titrations, ArCP and YbtE were both buffer exchanged >200-fold into NMR 
buffer + 0.05% NaN3. Samples were then concentrated and filtered. Concentration of YbtE 
and ArCP was determined as described for ITC experiments. For all experiments, ArCP 
was held at fixed concentration of 100 µM and the concentration of YbtE was varied. All 
samples contained 10% D2O and DSS for referencing. 
For holo-ArCP, 8 HN-HSQCs were collected in the following order described by the ratio 
of ArCP:YbtE: 1:0, 1:4, 1:2, 1:1, 1:0.5, 1:0.25, 1:0.375, 1:0.125. Each HN-HSQC was 
collected with 32 scans and 2048 (1H, 16.1095 ppm at 4.698 ppm) × 128 (15N, 30 ppm at 
117 ppm) complex points for a total acquisition time of 2 hours, 40 minutes. All spectra 
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were apodized and zero-filled to the nearest power of 2. Spectra were analyzed using 
CARA. 
For apo-ArCP, 6 HN-HSQCs spectra were collected in the same manner as for holo-ArCP 
and in the following order: 1:0, 1:1, 1:0.5, 1:0.25, 1:0.375, 1:0.125. Spectra were analyzed 
using CARA.  
Calculating Solvent Accessible Surface Area 
Solvent accessible surface (SAS) area was calculated using the AreaIMol program in CCP4 
with a probe solvent molecule radius of 1.4 angstroms. For the EntE:EntB complex, SAS 
was calculated for the full complex (PDB 3RG2) and PDBs generated from 3RG2 in which 
one of the binding partners was removed. For the PDB generated for EntB from 3RG2, the 
phosphopantetheine arm was removed from the PDB file.  
For analysis of DhbE, SAS was calculated for the full DhbE molecule (PDB 1MDF) and 
the isolated C-terminal domain, beginning at the conserved lysine in the linker between the 
sub-domains.  






Figure 5.1. Results of fluorescence anisotropy experiments in which the various forms of 
ArCP were titrated with YbtE. Note the different scale of the x-axis for the titration with 
apo-ArCP. Fits to a 1:1 specific binding model in Prism 5 gave KD’s of 68.6±9.62 µM (apo-
ArCP), 7.22±1.34 µM (holo-ArCP), and 4.70±1.10 µM (SalNH-ArCP). Each point shows 




Figure 5-2. Results of the ITC experiment in which YbtE was titrated into apo-ArCP. The 
top panel shows the baseline corrected raw data. The bottom panel shows the intergrated 
heats fit to a 1:1 model with the stoichiometry, association constant, enthalpy, and entropy 
of the interaction. The integrated heats of the last four injections were averaged and 
subtracted from all points prior to fitting in Origin. 
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Figure 5-3. Results of the ITC experiment in which YbtE was titrated into holo-ArCP. The 
top panel shows the baseline corrected raw data. The bottom panel shows the intergrated 
heats fit to a 1:1 model with the stoichiometry, association constant, enthalpy, and entropy 
of the interaction. The integrated heats of the last four injections were averaged and 
subtracted from all points prior to fitting in Origin.  
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Figure 5-4. Results of the ITC experiment in which YbtE was titrated into SalNH-ArCP. 
The top panel shows the baseline corrected raw data. The bottom panel shows the 
intergrated heats fit to a 1:1 model with the stoichiometry, association constant, enthalpy, 
and entropy of the interaction. The integrated heats of the last four injections were averaged 
and subtracted from all points prior to fitting in Origin.  
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Figure 5-5. Signals of apo-ArCP from HN-HSQCs showing a variety of responses to 
increasing concentrations of YbtE. Red: Free apo-ArCP. Blue: 1:0.25 apo-ArCP:YbtE. 
Green: 1:0.5 apo-ArCP:YbtE. Panels A and B show two signals that shift dramatically and 
show a marked decrease in intensity as the concentration of YbtE increases. C and D show 
two signals whose position changes modestly. Panels E and F show signals for three 
residues whose appearance is wholly unaffected by the addition of YbtE. The differential 
responses of these residues indicates a specific binding interaction between apo-ArCP and 




Figure 5-6. Signals of holo-ArCP from HN-HSQCs showing a variety of responses to 
increasing concentrations of YbtE. Red: Free holo-ArCP. Blue: 1:0.25 holo-ArCP:YbtE. 
Green: 1:0.5 holo-ArCP:YbtE. All panels show the same residues as in Figure 5-5. Panels 
A and B show two signals that disappear from the spectrum at low concentrations of YbtE. 
C and D show two signals whose position changes modestly before disappearing from the 
spectrum. Panels E and F show signals for three residues whose appearance is wholly 
unaffected by the addition of YbtE. The differential responses of these residues indicates a 
specific binding interaction between holo-ArCP and YbtE and allows us to identify a 
potential interaction surface. The response of the signals shown here is indicative of 
intermediate exchange and indicates a tighter interaction between holo-ArCP and YbtE 
than apo-ArCP and YbtE.  
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Figure 5.7. Residues from apo-ArCP affected by titration with YbtE. Residues whose 
signals showed little or no response to the presence of YbtE are colored in green. Residues 
whose signals passed a threshold chemical shift perturbation are colored by the apo-
ArCP:YbtE ratio at which that threshold was passed: Blue: 1:0.125; Cyan: 1:0.25; Grey: 
1:0.375. A) Residues likely involved in the interaction cluster along helices 2 and 3, near 
the PP attachment site (highlighted with an asterisk) and form a contiguous patch along the 
surface of apo-ArCP. B) No residues on loop 1 were identified as being involved in 
mediating the interaction between apo-ArCP and YbtE.  
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Figure 5.8. Residues from holo-ArCP affected by titration with YbtE. Residues whose 
signals showed little or no response to the presence of YbtE are colored in TV blue. 
Residues whose signals dropped below a threshold intensity are colored by the holo-
ArCP:YbtE ratio at which that threshold was passed: Red: 1:0.25; Pink: 1:0.375; Grey: 
1:0.5. A) Residues likely involved in the interaction cluster along helices 2 and 3, near the 
PP attachment site (highlighted with an asterisk) and form a contiguous patch along the 
surface of holo-ArCP. B) No residues on loop 1 were identified as being involved in 
mediating the interaction between holo-ArCP and YbtE. These titrations were done in the 
absence of substrates for the adenylation reaction (salicylate and ATP) or an adenylate 
mimic, which may further alter the nature of the interaction. Interaction between loop 1 
and YbtE may also be strengthened by substrate loading, which repositions loop 1 via 






Figure 5-9. Results of ITC experiments with Cy1 and A) holo-ArCP or B) SalNH-ArCP. 
Integrated heats from blank titrations of Cy1 into buffer and buffer into holo- or SalNH-
ArCP were subtracted from the integrated heats from the actual titrations and the resulting 
heats plotted in Prism 5. Neither experiment shows a pattern consistent with a specific 




Figure 5-10. Comparison of the thermodynamic parameters for the interaction between 
YbtE and apo- (Green), holo- (blue), and SalNH-ArCP (pink). The solid green bars show 
-TΔS and ΔG for apo-ArCP based on the ITC results. As the fluorescence anisotropy 
experiments gave a rather different KD (68.6 µM (FA) vs. 11.6 µM) and therefore ΔG, this 
will affect the calculated change in entropy. The checkered green bars show the ΔG as 
calculated using a KD of 68.6 µM and -TΔS based on this ΔG and the ΔH obtained from 
the ITC experiment. The difference between these two calculations does not substantially 
change the entropy:enthalpy balance and therefore does not alter the interpretation. This 
figure clearly shows that covalent modifications to ArCP alter the enthalpy/entropy balance 
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Table 5-1. List of binding constants and thermodynamic parameters determined by 
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